Summary of the repurposed drugs for BC discussed in the chapter.
\\n\\n
\\n"}]',published:!0,mainMedia:{caption:"Milestone",originalUrl:"/media/original/124"}},components:[{type:"htmlEditorComponent",content:'
Barely three months into the new year and we are happy to announce a monumental milestone reached - 150 million downloads.
\n\nThis achievement solidifies IntechOpen’s place as a pioneer in Open Access publishing and the home to some of the most relevant scientific research available through Open Access.
\n\nWe are so proud to have worked with so many bright minds throughout the years who have helped us spread knowledge through the power of Open Access and we look forward to continuing to support some of the greatest thinkers of our day.
\n\nThank you for making IntechOpen your place of learning, sharing, and discovery, and here’s to 150 million more!
\n\n\n\n\n'}],latestNews:[{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"},{slug:"introducing-intechopen-book-series-a-new-publishing-format-for-oa-books-20210915",title:"Introducing IntechOpen Book Series - A New Publishing Format for OA Books"}]},book:{item:{type:"book",id:"7908",leadTitle:null,fullTitle:"Emergency Medicine and Trauma",title:"Emergency Medicine and Trauma",subtitle:null,reviewType:"peer-reviewed",abstract:'From prehospital evaluation to management in the emergency department,"Emergency Medicine and Trauma" provides easily accessible information on the evaluation, diagnosis, and management of trauma care. Recognition of the multidisciplinary nature and complexity of trauma care, especially the philosophy of a teamwork approach, must be an integral part of trauma management. To help make logical diagnoses and treatment plans , you will learn: The use of a structured and prioritized approach to critically ill and injured patients according to the clinical need and assessment of acuity level; How to establish resuscitation (management) priorities in a multiply injured patient; How to demonstrate the ability to adopt a holistic (multidisciplinary, biopsychosocial) approach to trauma patients. The role of the emergency department and its staff in major incidents, to understand planning and be prepared for major incidents. This book is designed not only for emergency medical providers but also for \nmedical students.',isbn:"978-1-78985-094-9",printIsbn:"978-1-78985-093-2",pdfIsbn:"978-1-83962-231-1",doi:"10.5772/intechopen.77738",price:100,priceEur:109,priceUsd:129,slug:"emergency-medicine-and-trauma",numberOfPages:98,isOpenForSubmission:!1,isInWos:null,isInBkci:!1,hash:"4d0e9d0c91eff59a61e29cd67cbb036b",bookSignature:"Ozgur Karcioglu and Müge Günalp Eneyli",publishedDate:"October 2nd 2019",coverURL:"https://cdn.intechopen.com/books/images_new/7908.jpg",numberOfDownloads:6264,numberOfWosCitations:1,numberOfCrossrefCitations:2,numberOfCrossrefCitationsByBook:0,numberOfDimensionsCitations:2,numberOfDimensionsCitationsByBook:0,hasAltmetrics:1,numberOfTotalCitations:5,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"January 8th 2019",dateEndSecondStepPublish:"February 27th 2019",dateEndThirdStepPublish:"April 28th 2019",dateEndFourthStepPublish:"July 17th 2019",dateEndFifthStepPublish:"September 15th 2019",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"221195",title:"Prof.",name:"Ozgur",middleName:null,surname:"Karcioglu",slug:"ozgur-karcioglu",fullName:"Ozgur Karcioglu",profilePictureURL:"https://mts.intechopen.com/storage/users/221195/images/system/221195.jpeg",biography:"In 1994, I started residency in Dokuz Eylul University Medical School, Department of Emergency Medicine. I completed Fellowship Program in International EM in Pennsylvania State University (2005). I have served as the chairman of the department in DEU (2005-2007). I have been in charge of the ED of Bakirkoy Research and Training Hospital (2007-2009), and then faculty member in Acıbadem University (2009-15).\nI have served as a founder and a board member of The Emergency Medical Association of Turkey (2007-2009). 159 articles of mine were published in international journals. I have contributed in six books as editor, and authored 40 chapters. I’m serving as a member of The Editorial Board or as a section editor in a number of indexed journals. I’m also an instructor of the AHA-based Basic and Advanced Cardiac Life Support Course.",institutionString:"University of Health Sciences",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"4",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:{id:"270295",title:"Dr.",name:"Muge",middleName:"Gunalp",surname:"Eneyli",slug:"muge-eneyli",fullName:"Muge Eneyli",profilePictureURL:"https://mts.intechopen.com/storage/users/270295/images/10330_n.jpg",biography:"Dr. Günalp finished her residency in March 2004 at the Hacettepe University School of Medicine. She has been working as\na clinical instructor in the Department of Emergency Medicine,\nUniversity of Ankara, since. She has participated in emergency trauma care courses as an instructor since 2004. She also\norganized an advanced cardiac life support course in Turkey\nas a director between 2009 and 2012. At Ankara University\nSchool’s Department of Emergency Medicine she prepared a project to the EU\ncalled “Improving the Research Potential of Medical School of Ankara University\non Trauma Management System” for the Seventh Framework Programme (FP7)\nRegpot-2008-1. She also participated in this project as project manager. She participated in a core instructor course and became a BLS and ACLS instructor.",institutionString:"Ankara University School of Medicine",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:null},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1009",title:"Pre-Hospital Emergency Medicine",slug:"emergency-medicine-pre-hospital-emergency-medicine"}],chapters:[{id:"68200",title:"Pre-Hospital and Trauma Care to Road Traffic Accident Victims: Experiences of Residents Living along Accident-Prone Highways in Ghana",doi:"10.5772/intechopen.86118",slug:"pre-hospital-and-trauma-care-to-road-traffic-accident-victims-experiences-of-residents-living-along-",totalDownloads:996,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:1,abstract:"Road traffic accidents (RTAs) and associated injuries are a major public health problem in developing countries. The timely emergency pre-hospital care and subsequent transportation of accident victims to the health facility may help reduce the accident and injury outcomes. Available evidence suggests that RTA victims stand a greater chance of survival if attended to and cared for in a timely manner. This exploratory qualitative study set out to explore the experiences of residents of 12 communities along the Kasoa-Mankessim highway in Ghana (an accident-prone highway) in administering emergency pre-hospital care to RTA victims. We utilised data from a purposive sample of 80 respondents (i.e., people who have ever attended to RTA victims) from the communities through structured interview schedules. We found that the majority of the respondents had little knowledge and/or professional training in first-aid and emergency pre-hospital care to RTA victims. The skills and knowledge exhibited were gained through years of rescue services to RTA victims. The “scoop and run” method of first-aid care was predominant among the respondents. We recommend regular community member (layperson first responder) sensitisation and training on emergency pre-hospital care for RTA victims.",signatures:"Enoch F. Sam, David K. Blay, Samuel Antwi, Constance Anaafi and Juliet A. Adoma",downloadPdfUrl:"/chapter/pdf-download/68200",previewPdfUrl:"/chapter/pdf-preview/68200",authors:[{id:"271240",title:"Dr.",name:"Enoch F.",surname:"Sam",slug:"enoch-f.-sam",fullName:"Enoch F. Sam"},{id:"284406",title:"Mr.",name:"David K",surname:"Blay",slug:"david-k-blay",fullName:"David K Blay"},{id:"284407",title:"Mr.",name:"Samuel",surname:"Antwi",slug:"samuel-antwi",fullName:"Samuel Antwi"},{id:"284408",title:"Ms.",name:"Constance",surname:"Anarfi",slug:"constance-anarfi",fullName:"Constance Anarfi"},{id:"284587",title:"Ms.",name:"Juliet",surname:"Asum",slug:"juliet-asum",fullName:"Juliet Asum"}],corrections:null},{id:"67220",title:"Triage",doi:"10.5772/intechopen.86227",slug:"triage",totalDownloads:1029,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"During austere conditions when there is a large demand on healthcare services and the resources are limited for different reasons, there should be a special way of managing patients and victims in order to make the most benefit to the community. Trial of first come, first served will lead to losing most of the seriously injured patients because they will reach late if they reached a healthcare facility. In addition, day-to-day work protocols with full resources also are not the optimum to offer for the whole community during a major incident. Triage has been created and evolved in military medical services to face mass casualty with limited resources and then transferred to civilian life to deal with mass casualty incidents. Applying triage to patients created some interference with medical bioethics if those applied on individual bases, but if applied in the whole picture of state or country, we can understand its rations.",signatures:"Abdulnasir F.H. Aljazairi",downloadPdfUrl:"/chapter/pdf-download/67220",previewPdfUrl:"/chapter/pdf-preview/67220",authors:[{id:"229291",title:"Dr.",name:"Abdulnasir F.H.",surname:"Al-Jazairi",slug:"abdulnasir-f.h.-al-jazairi",fullName:"Abdulnasir F.H. Al-Jazairi"}],corrections:null},{id:"67641",title:"Prehospital Emergency Care in Acute Trauma Conditions",doi:"10.5772/intechopen.86776",slug:"prehospital-emergency-care-in-acute-trauma-conditions",totalDownloads:1163,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"It is well known at this moment that a systems and systematic approach to trauma care cases is ideal. The prehospital controversies of in-the-field care in trauma cases, resuscitation, and transport, ground or air, are still debated. The most controversial is rapid transport to definitive care (“scoop and run”) versus field stabilization in trauma, which remains a topic of debate and resulted in great variability of prehospital policy. Emergency medical services, including ground and air transportation, significantly extend the reach of tertiary care facilities, leading to rapid transport of critically ill patients. Emergency medical services (EMS) providers are the first link to a trauma care system, and trauma triage made by EMS personnel is also a very important factor in a good outcome of trauma patients. The assessment of patient and the treatment delivered by the first medical crew could have a large impact over the clinical evolution and output of trauma patient; that way, it is necessary to apply a systematic approach in this pathology, guided by clear and simple-to-follow recommendations applied on the scene. Recent review of the literature on helicopter emergency medical services (HEMS) showed an overall benefit of 2.7 additional lives saved per 100 HEMS activations.",signatures:"Tudor Ovidiu Popa, Diana Carmen Cimpoesu and Paul Lucian Nedelea",downloadPdfUrl:"/chapter/pdf-download/67641",previewPdfUrl:"/chapter/pdf-preview/67641",authors:[{id:"201934",title:"Prof.",name:"Carmen Diana",surname:"Cimpoesu",slug:"carmen-diana-cimpoesu",fullName:"Carmen Diana Cimpoesu"},{id:"203237",title:"Associate Prof.",name:"Tudor Ovidiu",surname:"Popa",slug:"tudor-ovidiu-popa",fullName:"Tudor Ovidiu Popa"},{id:"296801",title:"Dr.",name:"Paul Lucian",surname:"Nedelea",slug:"paul-lucian-nedelea",fullName:"Paul Lucian Nedelea"}],corrections:null},{id:"68241",title:"Treatment Toxicity: Radiation",doi:"10.5772/intechopen.88192",slug:"treatment-toxicity-radiation",totalDownloads:792,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"Radiation exposures, both intentional and unintentional, have influence on normal tissue function. Short-term and long-term injuries can occur to all cell systems of both limited and rapid self-renewal potential. Radiation effects can last a lifetime for a patient and can produce complications for all organs and systems. Often invisible at the time of exposure, the fingerprints for cell damage can appear at any timepoint after. Health-care providers will need comprehensive knowledge and understanding of the acute and late effects of radiation exposure and how these interrelate with immediate and long-term care.",signatures:"Thomas J. FitzGerald, Maryann Bishop-Jodoin, Fran Laurie, Matthew Iandoli, Ameer Elaimy, James Shen, Peter Lee, Alexander Lukez, Lakshmi Shanmugham, Beth Herrick, Jon Glanzman and David Goff",downloadPdfUrl:"/chapter/pdf-download/68241",previewPdfUrl:"/chapter/pdf-preview/68241",authors:[{id:"241806",title:"Dr.",name:"Thomas J.",surname:"FitzGerald",slug:"thomas-j.-fitzgerald",fullName:"Thomas J. FitzGerald"},{id:"303607",title:"Dr.",name:"Ameer",surname:"Elaimy",slug:"ameer-elaimy",fullName:"Ameer Elaimy"},{id:"303608",title:"Mr.",name:"James",surname:"Shen",slug:"james-shen",fullName:"James Shen"},{id:"303610",title:"Mr.",name:"Peter",surname:"Lee",slug:"peter-lee",fullName:"Peter Lee"},{id:"303611",title:"Mr.",name:"Alexander",surname:"Lukez",slug:"alexander-lukez",fullName:"Alexander Lukez"},{id:"303613",title:"Dr.",name:"Lakshmi",surname:"Shanmugham",slug:"lakshmi-shanmugham",fullName:"Lakshmi Shanmugham"},{id:"303614",title:"Dr.",name:"Jonathan",surname:"Glanzman",slug:"jonathan-glanzman",fullName:"Jonathan Glanzman"},{id:"308546",title:"Ms.",name:"Maryann",surname:"Bishop-Jodoin",slug:"maryann-bishop-jodoin",fullName:"Maryann Bishop-Jodoin"},{id:"312407",title:"Dr.",name:"Fran",surname:"Laurie",slug:"fran-laurie",fullName:"Fran Laurie"},{id:"312408",title:"Dr.",name:"Matthew",surname:"Iandoli",slug:"matthew-iandoli",fullName:"Matthew Iandoli"},{id:"312409",title:"Dr.",name:"Beth",surname:"Herrick",slug:"beth-herrick",fullName:"Beth Herrick"},{id:"312410",title:"Dr.",name:"David",surname:"Goff",slug:"david-goff",fullName:"David Goff"}],corrections:null},{id:"68195",title:"Vascular Trauma",doi:"10.5772/intechopen.88285",slug:"vascular-trauma",totalDownloads:1293,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:1,abstract:"Trauma is a leading cause of death and disability in young adults in developed countries with the high impact on future patient quality of life and productivity. The traumatic injury of the vessels is one of the most dangerous types of injury, requiring a fast and reliable diagnosis and, in vast majority of cases, immediate surgical treatment. In this chapter, the authors describe various types of vascular injuries according to injury types and locations. The prehospital care algorithms in patients with vascular trauma are proposed with the emphasis on bleeding control techniques and transportation technique to the nearest hospital. In the next subsection, the various peripheral vascular injuries of specific body areas are described. The truncal vessel trauma is discussed in the next subsection, focusing on fast diagnosis and decision on surgery. In the last subsection, a problem of iatrogenic vascular injury is described due to a rapid increase of minimally invasive techniques in which a vascular injury, as a complication of therapy, may occur.",signatures:"Krzysztof Szaniewski, Tomasz Byrczek and Tomasz Sikora",downloadPdfUrl:"/chapter/pdf-download/68195",previewPdfUrl:"/chapter/pdf-preview/68195",authors:[{id:"233455",title:"Ph.D.",name:"Krzysztof",surname:"Szaniewski",slug:"krzysztof-szaniewski",fullName:"Krzysztof Szaniewski"},{id:"308517",title:"Dr.",name:"Tomasz",surname:"Byrczek",slug:"tomasz-byrczek",fullName:"Tomasz Byrczek"},{id:"308519",title:"Dr.",name:"Tomasz",surname:"Sikora",slug:"tomasz-sikora",fullName:"Tomasz Sikora"}],corrections:null},{id:"67559",title:"Nail Trauma",doi:"10.5772/intechopen.86697",slug:"nail-trauma",totalDownloads:992,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"The nails are important elements of the finger, not only aesthetically, but also for its functionality. Not only to protecting the tip of the finger helps us but also to perform meticulously fine dexterity activities. Due to the high incidence of nail injuries seen in a trauma emergency service, it is essential to know, at least, basic aspects of the anatomy and physiology of the nail and what should be the appropriate treatment based on the injury presented by the patient. Injuries such as subungual hematomas are resolved in short time, however, more complex lesions require minor surgical intervention to obtain good results. In this chapter, additionally to reviewing the anatomy-physiological aspects of the nail, the principles of treatment of nail traumas are detailed.",signatures:"Rebeca Astorga Veganzones",downloadPdfUrl:"/chapter/pdf-download/67559",previewPdfUrl:"/chapter/pdf-preview/67559",authors:[{id:"296751",title:"Mrs.",name:"Rebeca",surname:"Astorga Veganzones",slug:"rebeca-astorga-veganzones",fullName:"Rebeca Astorga Veganzones"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"7111",title:"Poisoning in the Modern World",subtitle:"New Tricks for an Old Dog?",isOpenForSubmission:!1,hash:"08164f9300bc6bf4900c9166d960278b",slug:"poisoning-in-the-modern-world-new-tricks-for-an-old-dog-",bookSignature:"Ozgur Karcioglu and Banu Arslan",coverURL:"https://cdn.intechopen.com/books/images_new/7111.jpg",editedByType:"Edited by",editors:[{id:"221195",title:"Prof.",name:"Ozgur",surname:"Karcioglu",slug:"ozgur-karcioglu",fullName:"Ozgur Karcioglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6662",title:"Trauma Surgery",subtitle:null,isOpenForSubmission:!1,hash:"9721b9ac98bf237058cafd0a0303bdbc",slug:"trauma-surgery",bookSignature:"Ozgur Karcioglu and Hakan Topacoglu",coverURL:"https://cdn.intechopen.com/books/images_new/6662.jpg",editedByType:"Edited by",editors:[{id:"221195",title:"Prof.",name:"Ozgur",surname:"Karcioglu",slug:"ozgur-karcioglu",fullName:"Ozgur Karcioglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8266",title:"Cardiac Diseases and Interventions in 21st Century",subtitle:null,isOpenForSubmission:!1,hash:"186b2840cf326729108f409cd8f30bcc",slug:"cardiac-diseases-and-interventions-in-21st-century",bookSignature:"Ozgur Karcioglu",coverURL:"https://cdn.intechopen.com/books/images_new/8266.jpg",editedByType:"Edited by",editors:[{id:"221195",title:"Prof.",name:"Ozgur",surname:"Karcioglu",slug:"ozgur-karcioglu",fullName:"Ozgur Karcioglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"802",title:"Severe Sepsis and Septic Shock",subtitle:"Understanding a Serious Killer",isOpenForSubmission:!1,hash:"7ac9a759048ec9ec47c283813a4131cc",slug:"severe-sepsis-and-septic-shock-understanding-a-serious-killer",bookSignature:"Ricardo Fernandez",coverURL:"https://cdn.intechopen.com/books/images_new/802.jpg",editedByType:"Edited by",editors:[{id:"76827",title:"Dr.",name:"Ricardo",surname:"Fernandez",slug:"ricardo-fernandez",fullName:"Ricardo Fernandez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2583",title:"Sepsis",subtitle:"An Ongoing and Significant Challenge",isOpenForSubmission:!1,hash:"85121c8c358a97497c254ca2832be903",slug:"sepsis-an-ongoing-and-significant-challenge",bookSignature:"Luciano Azevedo",coverURL:"https://cdn.intechopen.com/books/images_new/2583.jpg",editedByType:"Edited by",editors:[{id:"72846",title:"Prof.",name:"Luciano",surname:"Azevedo",slug:"luciano-azevedo",fullName:"Luciano Azevedo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5202",title:"Extracorporeal Membrane Oxygenation",subtitle:"Advances in Therapy",isOpenForSubmission:!1,hash:"f7c8f9c0cf1cf50455fba7e2607e9268",slug:"extracorporeal-membrane-oxygenation-advances-in-therapy",bookSignature:"Michael S. Firstenberg",coverURL:"https://cdn.intechopen.com/books/images_new/5202.jpg",editedByType:"Edited by",editors:[{id:"64343",title:"Dr.",name:"Michael S.",surname:"Firstenberg",slug:"michael-s.-firstenberg",fullName:"Michael S. Firstenberg"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2621",title:"Hyperthermia",subtitle:null,isOpenForSubmission:!1,hash:"e3557de8bc852fa2c1a8b17e026cd37c",slug:"hyperthermia",bookSignature:"Nagraj Huilgol",coverURL:"https://cdn.intechopen.com/books/images_new/2621.jpg",editedByType:"Edited by",editors:[{id:"146901",title:"Dr.",name:"Nagraj",surname:"Huilgol",slug:"nagraj-huilgol",fullName:"Nagraj Huilgol"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1737",title:"Emergency Medicine",subtitle:"An International Perspective",isOpenForSubmission:!1,hash:"937b8698946595f200066b643e153534",slug:"emergency-medicine-an-international-perspective",bookSignature:"Michael Blaivas",coverURL:"https://cdn.intechopen.com/books/images_new/1737.jpg",editedByType:"Edited by",editors:[{id:"106834",title:"Dr.",name:"Michael",surname:"Blaivas",slug:"michael-blaivas",fullName:"Michael Blaivas"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5851",title:"Sepsis",subtitle:null,isOpenForSubmission:!1,hash:"140438644d49079e214fd82e9fe5e5ac",slug:"sepsis",bookSignature:"Vijay Kumar",coverURL:"https://cdn.intechopen.com/books/images_new/5851.jpg",editedByType:"Edited by",editors:[{id:"63844",title:"Dr.",name:"Vijay",surname:"Kumar",slug:"vijay-kumar",fullName:"Vijay Kumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5949",title:"Resuscitation Aspects",subtitle:null,isOpenForSubmission:!1,hash:"876e8435664e85af78acd71c44e3e0a4",slug:"resuscitation-aspects",bookSignature:"Theodoros Aslanidis",coverURL:"https://cdn.intechopen.com/books/images_new/5949.jpg",editedByType:"Edited by",editors:[{id:"200252",title:"Dr.",name:"Theodoros",surname:"Aslanidis",slug:"theodoros-aslanidis",fullName:"Theodoros Aslanidis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"66065",slug:"corrigendum-to-eating-disorders-as-new-forms-of-addiction",title:"Corrigendum to: Eating Disorders as New Forms of Addiction",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/66065.pdf",downloadPdfUrl:"/chapter/pdf-download/66065",previewPdfUrl:"/chapter/pdf-preview/66065",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/66065",risUrl:"/chapter/ris/66065",chapter:{id:"52200",slug:"eating-disorders-as-new-forms-of-addiction",signatures:"Francisco J. Vaz-Leal, María I. Ramos-Fuentes, Laura Rodríguez-\nSantos and M. Cristina Álvarez-Mateos",dateSubmitted:"June 28th 2016",dateReviewed:"August 12th 2016",datePrePublished:null,datePublished:"February 1st 2017",book:{id:"5372",title:"Eating Disorders",subtitle:"A Paradigm of the Biopsychosocial Model of Illness",fullTitle:"Eating Disorders - A Paradigm of the Biopsychosocial Model of Illness",slug:"eating-disorders-a-paradigm-of-the-biopsychosocial-model-of-illness",publishedDate:"February 1st 2017",bookSignature:"Ignacio Jauregui-Lobera",coverURL:"https://cdn.intechopen.com/books/images_new/5372.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"323887",title:"Prof.",name:"Ignacio",middleName:null,surname:"Jáuregui-Lobera",slug:"ignacio-jauregui-lobera",fullName:"Ignacio Jáuregui-Lobera"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"188555",title:"Prof.",name:"Francisco J.",middleName:null,surname:"Vaz-Leal",fullName:"Francisco J. Vaz-Leal",slug:"francisco-j.-vaz-leal",email:"fjvazleal@gmail.com",position:null,institution:null},{id:"188719",title:"Dr.",name:"María Cristina",middleName:null,surname:"Álvarez Mateos",fullName:"María Cristina Álvarez Mateos",slug:"maria-cristina-alvarez-mateos",email:"cristinaalvarezmateos@gmail.com",position:null,institution:null},{id:"195142",title:"Dr.",name:"Laura",middleName:null,surname:"Rodríguez Santos",fullName:"Laura Rodríguez Santos",slug:"laura-rodriguez-santos",email:"laura@unex.es",position:null,institution:null},{id:"195143",title:"Dr.",name:"María I",middleName:null,surname:"Ramos Fuentes",fullName:"María I Ramos Fuentes",slug:"maria-i-ramos-fuentes",email:"miramos@unex.es",position:null,institution:null}]}},chapter:{id:"52200",slug:"eating-disorders-as-new-forms-of-addiction",signatures:"Francisco J. Vaz-Leal, María I. Ramos-Fuentes, Laura Rodríguez-\nSantos and M. Cristina Álvarez-Mateos",dateSubmitted:"June 28th 2016",dateReviewed:"August 12th 2016",datePrePublished:null,datePublished:"February 1st 2017",book:{id:"5372",title:"Eating Disorders",subtitle:"A Paradigm of the Biopsychosocial Model of Illness",fullTitle:"Eating Disorders - A Paradigm of the Biopsychosocial Model of Illness",slug:"eating-disorders-a-paradigm-of-the-biopsychosocial-model-of-illness",publishedDate:"February 1st 2017",bookSignature:"Ignacio Jauregui-Lobera",coverURL:"https://cdn.intechopen.com/books/images_new/5372.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"323887",title:"Prof.",name:"Ignacio",middleName:null,surname:"Jáuregui-Lobera",slug:"ignacio-jauregui-lobera",fullName:"Ignacio Jáuregui-Lobera"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"188555",title:"Prof.",name:"Francisco J.",middleName:null,surname:"Vaz-Leal",fullName:"Francisco J. Vaz-Leal",slug:"francisco-j.-vaz-leal",email:"fjvazleal@gmail.com",position:null,institution:null},{id:"188719",title:"Dr.",name:"María Cristina",middleName:null,surname:"Álvarez Mateos",fullName:"María Cristina Álvarez Mateos",slug:"maria-cristina-alvarez-mateos",email:"cristinaalvarezmateos@gmail.com",position:null,institution:null},{id:"195142",title:"Dr.",name:"Laura",middleName:null,surname:"Rodríguez Santos",fullName:"Laura Rodríguez Santos",slug:"laura-rodriguez-santos",email:"laura@unex.es",position:null,institution:null},{id:"195143",title:"Dr.",name:"María I",middleName:null,surname:"Ramos Fuentes",fullName:"María I Ramos Fuentes",slug:"maria-i-ramos-fuentes",email:"miramos@unex.es",position:null,institution:null}]},book:{id:"5372",title:"Eating Disorders",subtitle:"A Paradigm of the Biopsychosocial Model of Illness",fullTitle:"Eating Disorders - A Paradigm of the Biopsychosocial Model of Illness",slug:"eating-disorders-a-paradigm-of-the-biopsychosocial-model-of-illness",publishedDate:"February 1st 2017",bookSignature:"Ignacio Jauregui-Lobera",coverURL:"https://cdn.intechopen.com/books/images_new/5372.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"323887",title:"Prof.",name:"Ignacio",middleName:null,surname:"Jáuregui-Lobera",slug:"ignacio-jauregui-lobera",fullName:"Ignacio Jáuregui-Lobera"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"9538",leadTitle:null,title:"Demographic Analysis",subtitle:"Selected Concepts, Tools, and Applications",reviewType:"peer-reviewed",abstract:"Demographic Analysis - Selected Concepts, Tools, and Applications presents basic definitions, practical techniques, and methods, as well as examples of studies based on the usage of demographic analysis in various institutions and economic entities. The volume covers studies related to population distribution, urbanization, migration, population change and dynamics, aging, longevity, population theories, and population projections. It is an asset to academic and professional communities interested in advancing knowledge on diverse populations in various contexts such as public policies, public services, education, and labor markets. The book aims to help students of demography as well as practitioners of other fields of social sciences and people in government, business, and nonprofit organizations.",isbn:"978-1-83969-188-1",printIsbn:"978-1-83969-187-4",pdfIsbn:"978-1-83969-189-8",doi:"10.5772/intechopen.87333",price:119,priceEur:129,priceUsd:155,slug:"demographic-analysis-selected-concepts-tools-and-applications",numberOfPages:240,isOpenForSubmission:!1,isSalesforceBook:!1,isNomenclature:!1,hash:"f335c5d0a39e8631d8627546e14ce61f",bookSignature:"Andrzej Klimczuk",publishedDate:"November 3rd 2021",coverURL:"https://cdn.intechopen.com/books/images_new/9538.jpg",keywords:null,numberOfDownloads:2538,numberOfWosCitations:0,numberOfCrossrefCitations:1,numberOfDimensionsCitations:2,numberOfTotalCitations:3,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"October 22nd 2020",dateEndSecondStepPublish:"December 1st 2020",dateEndThirdStepPublish:"January 30th 2021",dateEndFourthStepPublish:"April 20th 2021",dateEndFifthStepPublish:"June 19th 2021",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"2 years",secondStepPassed:!0,areRegistrationsClosed:!0,currentStepOfPublishingProcess:5,editedByType:"Edited by",kuFlag:!1,biosketch:"Dr. Andrzej Klimczuk is a sociologist and public policy expert, member of various scientific organizations such as the Polish Sociological Association, Polish Society of Gerontology, and European Sociological Association. He also works as an external expert of institutions such as the European Commission, URBACT III Programme, Interreg CENTRAL EUROPE Programme, and Fondazione Cariplo.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"320017",title:"Ph.D.",name:"Andrzej",middleName:null,surname:"Klimczuk",slug:"andrzej-klimczuk",fullName:"Andrzej Klimczuk",profilePictureURL:"https://mts.intechopen.com/storage/users/320017/images/system/320017.jpg",biography:"Andrzej Klimczuk, Ph.D., is a sociologist, public policy expert, and assistant professor in the Department of Public Policy of the Collegium of Socio-Economics, SGH Warsaw School of Economics, Poland. He worked as an external expert for institutions such as the European Commission, Interreg CENTRAL EUROPE Programme, and Fondazione Cariplo. Dr. Klimczuk has authored many scientific papers in the fields of gerontology, labor economics, public management, and social policy. His recent monographs include Economic Foundations for Creative Ageing Policy, Generations, Intergenerational Relationships, Generational Policy, and Perspectives and Theories of Social Innovation for Ageing Population.",institutionString:"Warsaw School of Economics",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Warsaw School of Economics",institutionURL:null,country:{name:"Poland"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"281",title:"Sociology",slug:"sociology"}],chapters:[{id:"78906",title:"Introductory Chapter: Demographic Analysis",slug:"introductory-chapter-demographic-analysis",totalDownloads:369,totalCrossrefCites:0,authors:[{id:"320017",title:"Ph.D.",name:"Andrzej",surname:"Klimczuk",slug:"andrzej-klimczuk",fullName:"Andrzej Klimczuk"}]},{id:"75618",title:"Demographic Analysis and the Decomposition of Social Change",slug:"demographic-analysis-and-the-decomposition-of-social-change",totalDownloads:331,totalCrossrefCites:0,authors:[{id:"338748",title:"Prof.",name:"Parfait",surname:"Eloundou-Enyegue",slug:"parfait-eloundou-enyegue",fullName:"Parfait Eloundou-Enyegue"},{id:"338749",title:"Dr.",name:"Sarah",surname:"Giroux",slug:"sarah-giroux",fullName:"Sarah Giroux"},{id:"338750",title:"Dr.",name:"Michel",surname:"Tenikue",slug:"michel-tenikue",fullName:"Michel Tenikue"}]},{id:"75780",title:"Geographies of Ageing: A Visuospatial Approach to Demographic Change in Australia",slug:"geographies-of-ageing-a-visuospatial-approach-to-demographic-change-in-australia",totalDownloads:276,totalCrossrefCites:0,authors:[{id:"337661",title:"Dr.",name:"Hamish",surname:"Robertson",slug:"hamish-robertson",fullName:"Hamish Robertson"},{id:"346245",title:"Mr.",name:"Nick",surname:"Nicholas",slug:"nick-nicholas",fullName:"Nick Nicholas"}]},{id:"77806",title:"Demographic Transition in Sub-Saharan Africa: From Grassroots to Ivory Towers",slug:"demographic-transition-in-sub-saharan-africa-from-grassroots-to-ivory-towers",totalDownloads:144,totalCrossrefCites:0,authors:[{id:"287573",title:"Dr.",name:"Kelvin",surname:"Leshabari",slug:"kelvin-leshabari",fullName:"Kelvin Leshabari"}]},{id:"75918",title:"Variations in First Union Dissolution Patterns among the Lebou, Peuhl, Sereer, Toucouleur, and Wolof in Senegal",slug:"variations-in-first-union-dissolution-patterns-among-the-lebou-peuhl-sereer-toucouleur-and-wolof-in-",totalDownloads:153,totalCrossrefCites:0,authors:[{id:"339826",title:"Dr.",name:"Justin",surname:"Dansou",slug:"justin-dansou",fullName:"Justin Dansou"}]},{id:"76794",title:"The Age-Sex Structure of Religion as a Determinant of the Social Inclusion of Internal Migrants in Maroua",slug:"the-age-sex-structure-of-religion-as-a-determinant-of-the-social-inclusion-of-internal-migrants-in-m",totalDownloads:197,totalCrossrefCites:0,authors:[{id:"285893",title:"Dr.",name:"Nanche Billa",surname:"Robert",slug:"nanche-billa-robert",fullName:"Nanche Billa Robert"}]},{id:"75431",title:"Age at First Marriage of Women in Bangladesh: Levels, Trends and Determinants",slug:"age-at-first-marriage-of-women-in-bangladesh-levels-trends-and-determinants",totalDownloads:411,totalCrossrefCites:0,authors:[{id:"340753",title:"Prof.",name:"Mohammad Salim",surname:"Zahangir",slug:"mohammad-salim-zahangir",fullName:"Mohammad Salim Zahangir"},{id:"340768",title:"Mrs.",name:"Mosammat Zamilun",surname:"Nahar",slug:"mosammat-zamilun-nahar",fullName:"Mosammat Zamilun Nahar"}]},{id:"77155",title:"The City of L’Aquila after the 2009 Earthquake: Review of Connections between Depopulation, Identity and Continuity",slug:"the-city-of-l-aquila-after-the-2009-earthquake-review-of-connections-between-depopulation-identity-a",totalDownloads:287,totalCrossrefCites:0,authors:[{id:"342642",title:"Dr.",name:"Stefano",surname:"Gizzi",slug:"stefano-gizzi",fullName:"Stefano Gizzi"}]},{id:"76336",title:"Health Seeking Behaviors among Displaced Populations/Refugees",slug:"health-seeking-behaviors-among-displaced-populations-refugees",totalDownloads:120,totalCrossrefCites:0,authors:[{id:"342365",title:"Dr.",name:"Chika",surname:"Ejike",slug:"chika-ejike",fullName:"Chika Ejike"}]},{id:"76983",title:"Researching into Commitments for Sustainable Development Goals and Healthy Aging",slug:"researching-into-commitments-for-sustainable-development-goals-and-healthy-aging",totalDownloads:256,totalCrossrefCites:1,authors:[{id:"344582",title:"Dr.",name:"Santosh Kumar",surname:"Mishra",slug:"santosh-kumar-mishra",fullName:"Santosh Kumar Mishra"}]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"247865",firstName:"Jasna",lastName:"Bozic",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/247865/images/7225_n.jpg",email:"jasna.b@intechopen.com",biography:"As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"5810",title:"Socialization",subtitle:"A Multidimensional Perspective",isOpenForSubmission:!1,hash:"bfac2e9c0ec2963193e9d15d617c6a01",slug:"socialization-a-multidimensional-perspective",bookSignature:"Rosalba Morese, Sara Palermo and Juri Nervo",coverURL:"https://cdn.intechopen.com/books/images_new/5810.jpg",editedByType:"Edited by",editors:[{id:"214435",title:"Dr.",name:"Rosalba",surname:"Morese",slug:"rosalba-morese",fullName:"Rosalba Morese"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10656",title:"Intellectual Property",subtitle:null,isOpenForSubmission:!1,hash:"135df9b403b125a6458eba971faab3f6",slug:"intellectual-property",bookSignature:"Sakthivel Lakshmana Prabu and Timmakkondu Narasimman Kuppusami Suriyaprakash",coverURL:"https://cdn.intechopen.com/books/images_new/10656.jpg",editedByType:"Edited by",editors:[{id:"91590",title:"Dr.",name:"Sakthivel",surname:"Lakshmana Prabu",slug:"sakthivel-lakshmana-prabu",fullName:"Sakthivel Lakshmana Prabu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10227",title:"Rural Development",subtitle:"Education, Sustainability, Multifunctionality",isOpenForSubmission:!1,hash:"091e1f8266ec9fc776113a71c002cf7f",slug:"rural-development-education-sustainability-multifunctionality",bookSignature:"Paola de Salvo and Manuel Vaquero Piñeiro",coverURL:"https://cdn.intechopen.com/books/images_new/10227.jpg",editedByType:"Edited by",editors:[{id:"289820",title:"Prof.",name:"Paola",surname:"de Salvo",slug:"paola-de-salvo",fullName:"Paola de Salvo"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10785",title:"Suicide",subtitle:null,isOpenForSubmission:!1,hash:"f8ad2d5c55e4551a2e1046369cae627f",slug:"suicide",bookSignature:"Robert W. Motta",coverURL:"https://cdn.intechopen.com/books/images_new/10785.jpg",editedByType:"Edited by",editors:[{id:"262071",title:"Prof.",name:"Robert W.",surname:"Motta",slug:"robert-w.-motta",fullName:"Robert W. Motta"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7781",title:"Improving Quality of Life",subtitle:"Exploring Standard of Living, Wellbeing, and Community Development",isOpenForSubmission:!1,hash:"8130b1bca2a4feb7f313f127d302dcdd",slug:"improving-quality-of-life-exploring-standard-of-living-wellbeing-and-community-development",bookSignature:"Ryan Merlin Yonk",coverURL:"https://cdn.intechopen.com/books/images_new/7781.jpg",editedByType:"Edited by",editors:[{id:"196259",title:"Dr.",name:"Ryan Merlin",surname:"Yonk",slug:"ryan-merlin-yonk",fullName:"Ryan Merlin Yonk"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10233",title:"Sedentary Behaviour",subtitle:"A Contemporary View",isOpenForSubmission:!1,hash:"183415731897b5968c083dbdbef71553",slug:"sedentary-behaviour-a-contemporary-view",bookSignature:"Adilson Marques and Élvio Rúbio Gouveia",coverURL:"https://cdn.intechopen.com/books/images_new/10233.jpg",editedByType:"Edited by",editors:[{id:"210561",title:"Prof.",name:"Adilson",surname:"Marques",slug:"adilson-marques",fullName:"Adilson Marques"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7802",title:"Modern Slavery and Human Trafficking",subtitle:null,isOpenForSubmission:!1,hash:"587a0b7fb765f31cc98de33c6c07c2e0",slug:"modern-slavery-and-human-trafficking",bookSignature:"Jane Reeves",coverURL:"https://cdn.intechopen.com/books/images_new/7802.jpg",editedByType:"Edited by",editors:[{id:"211328",title:"Prof.",name:"Jane",surname:"Reeves",slug:"jane-reeves",fullName:"Jane Reeves"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7810",title:"Quality of Life",subtitle:"Biopsychosocial Perspectives",isOpenForSubmission:!1,hash:"0392d2712c58885b729bd943f9aac37f",slug:"quality-of-life-biopsychosocial-perspectives",bookSignature:"Floriana Irtelli, Federico Durbano and Simon George Taukeni",coverURL:"https://cdn.intechopen.com/books/images_new/7810.jpg",editedByType:"Edited by",editors:[{id:"174641",title:"Dr.",name:"Floriana",surname:"Irtelli",slug:"floriana-irtelli",fullName:"Floriana Irtelli"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6927",title:"Intellectual Property Rights",subtitle:"Patent",isOpenForSubmission:!1,hash:"9fd5884b3bce2ec6f77a8356ea384a37",slug:"intellectual-property-rights-patent",bookSignature:"Sakthivel Lakshmana Prabu, Suriyaprakash Tnk, Eduardo Jacob-Lopes and Leila Queiroz Zepka",coverURL:"https://cdn.intechopen.com/books/images_new/6927.jpg",editedByType:"Edited by",editors:[{id:"91590",title:"Dr.",name:"Sakthivel",surname:"Lakshmana Prabu",slug:"sakthivel-lakshmana-prabu",fullName:"Sakthivel Lakshmana Prabu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6483",title:"Classes",subtitle:"From National to Global Class Formation",isOpenForSubmission:!1,hash:"3666ae0858b15a8a16846d8d53b40f91",slug:"classes-from-national-to-global-class-formation",bookSignature:"Hardy Hanappi",coverURL:"https://cdn.intechopen.com/books/images_new/6483.jpg",editedByType:"Edited by",editors:[{id:"145817",title:"Prof.",name:"Hardy",surname:"Hanappi",slug:"hardy-hanappi",fullName:"Hardy Hanappi"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"45258",title:"Profunda Artery Perforator (PAP) Flap for Breast Reconstruction",doi:"10.5772/56332",slug:"profunda-artery-perforator-pap-flap-for-breast-reconstruction",body:'
Perforator flap breast reconstruction has strong appeal for many women undergoing mastectomies, but the procedure requires adequate donor site tissue. The most common donor site for perforator flap breast reconstruction is the abdomen, such as the deep inferior epigastric perforator (DIEP) or superficial inferior epigastric artery (SIEA) flap, as most women have adequate donor site tissue, the procedure may be performed in the supine position, and the perforating vessels have a dependable caliber and length. In the past, the second line option was usually the buttock, but the buttock as a donor site had multiple disadvantages – most notably a short vascular pedicle, a deforming donor site defect, and a long operative time due to the need to reposition the patient for harvest and inset. Recently, the posterior thigh has emerged as an excellent donor site for perforator flap breast reconstruction. Indeed, the profunda artery perforator (PAP) flap, which uses the skin and fat of the posterior thigh, has surpassed the gluteal artery perforator (GAP) flap in our practice as the second line donor site for microsurgical breast reconstruction.
The PAP flap for breast reconstruction was originated in 2010 by Dr. Robert J. Allen at the 13th International Course on Perforator Flaps in Mexico City. The first patient was a 52-year-old woman who had undergone previous attempts at breast reconstruction with a failed transverse rectus abdominis muscle (TRAM) flap and a failed implant. She wanted autologous tissue reconstruction, and other options considered for her included the superior gluteal artery perforator (SGAP) flap, inferior gluteal artery perforator (IGAP) flap, and the transverse upper gracilis (TUG) flap. Of note, however, the patient had excess posterior thigh tissue, and she did not want to sacrifice her muscle for breast reconstruction. While posterior thigh perforator flaps based on the inferior gluteal artery or profunda femoris artery had previously been described in the literature,[1-3] they had not been performed for breast reconstruction. Cadaver studies had demonstrated that the dominant blood supply to the posterior thigh was the posterior perforators emerging from the profunda femoris artery (Figure 1). Given the patient’s history, body habitus, and background work by other surgeons and anatomists, Dr. Allen decided to proceed with the first posterior thigh profunda artery perforator (PAP) flap for microsurgical breast reconstruction.
Cadaver studies had demonstrated that the dominant blood supply to the posterior thigh was the posterior perforators emerging from the profunda femoris artery.
With the midline and inferior gluteal crease as reference points, the largest, most well-placed perforators with the longest vascular pedicle can be identified. In this image, the best perforators have been identified as R3 and L1.
The PAP flap is appropriate for women with insufficient abdominal tissue, previous abdominal liposuction or surgery, a failed TRAM/DIEP/SIEA, pear-shaped body habitus, or who simply have a preference for a non-abdominal donor site. The donor site is the area on the posterior thigh found inferior to the gluteal crease. Excess posterior thigh fat is difficult to address by diet and exercise, and is accentuated in women who are pear-shaped. Even in women who are very thin, there is almost always a “banana roll” of excess skin and fatty tissue located on the back of the thigh below the buttock crease. Removal of the transverse posterior thigh tissue provides contouring and lifting to the thigh area, creates a rounder and more shapely buttock, and does not result in sciatic nerve exposure. The scar is usually concealed within a bathing suit, and the tissue is very soft and pliable.
In breast reconstruction, the PAP flap is coned to create a natural aesthetic breast shape with ample volume for most patients. Even in patients with a BMI < 18, the PAP flap can be successfully used for a very attractive breast reconstruction. The PAP flap skin paddle usually measures 4-7 cm in width and 26 cm in length. Volumes range from 150-900 grams, but in the average patient the volume is between 300-400 grams. Since no muscle is removed, postoperative pain and functional problems are minimized.
Once the decision has been made to proceed with a PAP flap, each of our patients undergoes a magnetic resonance (MR) or computed tomography (CT) angiogram pre-operatively to determine perforator size and intra-operative course. MR or CT angiography of the pelvis and thigh with contrast is performed in the supine position. Preoperative imaging with MRA or CTA makes it possible to define the intramuscular course of perforators prior to the flap elevation.[4-8] This makes it possible to quickly and accurately identify the size, location, and route of target perforators before the operative procedure. With the midline and inferior gluteal crease as reference points, the largest, most well-placed perforators with the longest vascular pedicle can be identified (Figure 2). Ideally, we choose the medial perforator closest to the inferior gluteal crease and just posterior to the gracilis muscle for ease of dissection in the supine/frog leg position. Three-dimensional MRA reconstruction allows the surgeon to visualize the placement of the perforators prior to marking (Figure 3).
Three-dimensional magnetic resonance angiography (MRA) reconstruction allows the surgeon to visualize perforator placement prior to marking. The best perforator will be chosen on the basis of location and caliber.
Once the perforators have been selected, the patient is marked one day before surgery. Based on the preoperative imaging, a handheld Doppler probe is used to identify and mark the skin perforators (Figure 4). Typically, there are both medial and lateral perforators, but we usually favor the medial perforators because they are easier to harvest in the supine position. The medial perforator usually enters posterior to the gracilis muscle. There have been some situations in which a more posterior and lateral perforator was dominant and therefore used. The superior marking is at the gluteal fold. The inferior marking is less than 6 cm below the superior marking. The flap is designed in a crescent shape so the scar does not extend onto the visible lateral or medial thigh outside of the gluteal fold. Once the marks are drawn, we listen with a hand held doppler to identify the arterial signal.
Once the perforators have been selected, we see the patient the day before surgery to apply the marks. Based on the preoperative imaging, the previously identified perforators are transposed onto the patient’s body. A handheld Doppler probe is used to confirm and mark the skin perforators one day prior to surgery. The squiggly marks indicate additional fat that will be captured with beveling.
The posterior thigh tissue is bordered by the iliotibial tract and adductor muscles horizontally, and the gluteal fold and popliteal fossa vertically. The profunda femoris artery enters the posterior compartment of the thigh and typically gives off three main perforators. The first perforator supplies the adductor magnus and gracilis, and the second and third perforators supply the semimembranosus, biceps femoris, and vastus lateralis.
On the day of surgery each of our patients receive 5000 units of subcutaneous heparin and perioperative intravenous antibiotics. The operation is performed under general anesthesia. Once general anesthesia is administered, the patient is prepped to include the upper thighs into the field. Sequential compression stockings are placed and wrapped with sterile towels and drapes. Flap harvest may be performed in the supine or prone position. The supine frog-leg position offers the advantage of decreased operative time because of rapid dissection from a medial approach and the lack of a need for repositioning. The prone position uses a lateral approach and maintains the possibility of conversion to a transverse upper gracilis flap if no adequate perforators are identified. When the supine approach is used, there is no specific bailout flap, and therefore preoperative imaging is essential.
When in the preferred supine position, the patient’s legs are placed in a frog leg position. Using a 10-blade scalpel, the incision is made on the crescent-shaped skin island designed on the thigh down to the subcutaneous fat, and the skin and fat raised above the muscles of the inner thigh. When the most lateral markings need to be incised, the leg is placed medial to access the lateral/posterior thigh region. The leg is placed back into frog leg position and beveling inferior is performed to capture as much fat as possible. In the supine position, the fascia is entered over the gracilis muscle and the vascular pedicle is identified approximately 3 cm posterior to the gracilis muscle. Careful dissection is performed to identify the perforating branch from the profunda femoris artery which supplies the flap with blood. Staying above the fascia until the posterior border of the gracilis is identified, the fascia is incised and the perforator is found in relation to the gracilis muscle. Once the key perforator is identified, standard perforator dissection proceeds to harvest the desired pedicle length and vessel diameter (Figure 5). Creating adequate exposure to ligate the tiny branches that enter the muscle, the pedicle elongates until its caliber is consistent consistent with the internal mammary artery. It is helpful to obtain wide exposure with fish hooks and Gelpi retractors, advancing the Gelpi retractors as the dissection proceeds. The vessel is then followed back toward the main profunda artery to its parent vessel (Figure 6).
Careful dissection is performed to identify the perforating branch from the profunda femoris artery which supplies the flap with blood. Staying above the fascia until the posterior border of the gracilis is identified, the fascia is incised and the perforator is found in relation to the gracilis muscle. Once the key perforator is identified, standard perforator dissection proceeds to harvest the desired pedicle length and vessel diameter.
It is helpful to obtain adequate exposure with fish hook retractors and Gelpi retractors, advancing the Gelpi retractors as the dissection proceeds. The vessel is then followed back toward the main profunda artery to its parent vessel.
After recipient-site preparation, the anastomosis is performed. The internal mammary artery and vein are prepared in the chest and the flap is then harvested, weighed and transferred to the breast. Once on the chest, the PAP flap vessels are anastomosed to the internal mammary vessels using microsurgery. The profunda perforator vein is anastomosed to the internal mammary vein using a venous coupler with sizes ranging from 2.0 to 3.0 mm. The artery is addressed next. Using a 9-0 nylon, the profunda artery is anastomosed to the internal mammary artery with either a continuous suture or interrupted sutures. If the flap is buried, an internal Doppler monitoring device is used. If a skin island is used, an internal Doppler device is usually unnecessary. Either way, the flap is deepithelialized and inset. After blood flow is reestablished, the flap is coned and shaped in a manner similar to the TUG flap for breast reconstruction (Figure 7).
After blood flow is reestablished, the flap is coned and shaped in a manner similar to the TUG flap for breast reconstruction.
The donor site is closed in a multilayer fashion over a drain. Meticulous closure of the posterior thigh donor site must be performed in order to achieve primary wound healing and avoid subsequent wound dehiscence. The superior aspect of the donor site incision needs to be tacked down with 2-0 vicryl to preserve the gluteal crease and to prevent inferior migration of the scar onto the thigh. The postoperative appearance of a PAP flap breast reconstruction creates an uplifted and conical aesthetically pleasing breast shape (Figure 8). The donor site is also usually well-concealed (Figure 9).
The postoperative appearance of a PAP flap breast reconstruction creates an uplifted and conical aesthetically pleasing breast shape.
The donor site is also usually well-concealed.
The postoperative care is similar to other perforator flaps such as the DIEP or GAP flaps. On postoperative day one, the Foley catheter, blood pressure cuff, oxygen, and intravenous fluids are discontinued. Patients may start a regular diet. Pain is usually well-controlled by oral medications. Although the patient may ambulate or sit with minimal discomfort, strenuous exercise should be avoided for 6-8 weeks. Patients usually stay in the hospital 3-4 days to monitor the blood flow into the free flap. When discharged, the patient may walk without difficulty, but some have reported temporary tightness in the posterior thigh. Other potential complications include posterior thigh numbness, donor site dehiscence, seroma, hematoma, takeback, flap loss and other potential complications of microvascular surgery.
Most microsurgeons who perform autologous tissue breast reconstruction select the abdomen as their first choice in donor site. We agree with this choice; we also prefer the abdomen as our primary donor site for autologous tissue breast reconstruction. Our second choice donor site for microsurgical breast reconstruction, however, is the posterior thigh. Like the abdomen, the posterior thigh donor site does not require positioning changes during the operative procedure. The patient can remain supine for both flap harvest and inset, which minimizes the anesthesia time for the patient. Finally, patients report minimal pain at the donor site. Anecdotally, they seem to ambulate and mobilize earlier than patients who undergo abdominal flap harvest.
The advantage to the PAP flap is a natural shape with ample volume in most cases. The scar is usually well-concealed when wearing a bathing suit. The pedicle length usually ranges from 8-10 cm, and is a good size match to the internal mammary vessels. Disadvantages include possible inferior location of the perforator causing the scar to be placed lower on the thigh in a more conspicuous position. This may be revised in a secondary procedure to raise the scar so that it is camouflaged in the gluteal fold. In very large-breasted women, the posterior thigh donor site may not be adequate. In such cases, additional procedures used to obtain volume such as fat grafting or rotational flaps may also be performed at a second stage.
Developments in radiographic imaging have supported preoperative flap design and planning. The ability to identify perforators preoperatively has decreased the level of difficulty for perforator flaps. Intraoperative flap elevation is now more predictable and straightforward, which makes dissection faster and easier. Hypothetically, easier perforator flap dissection should also lead to a lower complication rate. We feel that the PAP flap is a viable technique for autologous tissue breast reconstruction that may be easier to master than the traditional GAP procedures. In conclusion, we recommend the PAP flap as a simple and reliable approach to perforator flaps for microsurgical breast reconstruction.
Drug discovery is a multifaceted process that aims at identifying a therapeutic agent that can be useful in treating and managing certain medical conditions. This process includes identification of candidates, characterization, validation, optimization, screening, and assays for therapeutic effectiveness. If a molecule achieves acceptable results in these studies, then the molecule has to go through drug development processes and be recruited to clinical trials [1]. Several drug candidates (about 90%) have collapsed in early clinical trials due to unexpected results such as adverse effects or inadequate effectiveness [2, 3]. Drug development is probably among the most complicated and challenging processes in biomedical research. Apart from the already enormous complexities underlying pharmacological drug designs, additional significant challenges arise from clinical, regulatory, intellectual property, and commercial constraints. Such as challenging atmosphere has made the drug development process very sluggish and unpredictable [4]. The process of discovering and developing a new drug is a lengthy and expensive process taking somewhere from 10 to 15 years and costs about US$2–3 billion [1]. Despite massive sums of money being spent on drug development, no substantial rise in the new therapeutic drug agents in a clinical setting has been observed over several decades. Although overall global R&D spending for drug discovery has risen 10-fold from 1975 (the US $4 billion) to 2009 ($40 billion), the number of novel molecular entities (NMEs) approved has stayed essentially constant since 1975 (26 new drugs approved in 1976 and 27 new drugs approved in 2013) [5].
The essential step in discovering new drugs involves the evaluation of the safety and effectiveness of new drug candidates in human subjects, and it consists of four phases. In Phase I clinical trial, the candidate drug’s safety is assessed in a small population (20–80 individuals) to establish safe dose range and uncover adverse effects. Phase II involves the examination of intervention for its effectiveness and safety in large populations (a few hundred people). Phase III further involves the assessment of drug efficacy in a large population (several thousand) and compares new drug candidates with standard or experimental treatments. Phase IV is conducted when the intervention is marketed. This study aims to track how well the approved treatment is performing in the general population and gather data on side effects that may arise from broad usage over time. Phase III studies determine whether or not a medication is effective, and if so, FDA clearance is granted. The FDA approves one anticancer treatment out of every 5000–10,000 applicants, and just 5% of oncology medicines entering Phase I clinical trials are approved in the end. Because of the increased cost and time frame for new medication development in recent years, patients with severe illness may die until alternative therapies are available if they develop resistance to current therapy [6]. In searching for an alternative treatment option for managing various diseases, including cancer, the researchers have shifted their focus to drug repurposing strategies.
The drug purposing or drug reprofiling or drug redesigning process explores the therapeutic use of existing clinically approved, off patent drugs with known targets for another indication to minimize the cost of therapy, time, and risk [7]. The huge benefit of drug repurposing is that the efficacy, pharmacokinetics, pharmacodynamics, and toxicity characteristics have previously been explored in preclinical and Phase I investigation. These drug moieties may thus be quickly made to proceed to Phase II and Phase III clinical trials, and hence related developmental costs might be substantially lowered [6, 8]. The failure risk in drug development is low because
Outline of developing new drug versus repurposing.
The development of new drugs for breast cancer like any other cancer is a multistep process that includes drug designing, synthesis, characterization, safety and efficacy assessment, and finally, regulatory approval (Figure 2). The overall process is very lengthy and involves significant financial expenditure [11]. Further, the sky-high cost of the therapies and associated side effects make it desirable to look for other approaches to manage cancer effectively. Therefore, concurrently with the synthesis and design of new therapeutic modalities, various strategies should be considered for repurposing various already approved drugs that may target this deadly disease.
The time taken by the conventional of process of drug development with respect to drug repurposing. Conventional drug development process takes around 5 years and the same can be minimized to 5 years.
Aspirin was originally discovered in 1897 and was first commercialized as an analgesic. It has been utilized as an anti-inflammatory medication and for managing arterial and venous thrombosis [12]. Recent research has sparked interest in the usage of Aspirin for the prevention of various cancers. There are compelling evidences authenticating that regular use of low doses of aspirin results in a significant reduction in the occurrences and mortality of various cancers [13, 14, 15, 16, 17]. The possibility that Aspirin has an anticancer benefit has received considerable interest nowadays, with a lot of research being done to figure out how successful it is in the prevention of colorectal cancer [18], lung cancer [19], gastric cancer [20], prostate cancer [21], and many other cancers including breast cancer. Because of the effect of Aspirin in several biological processes such as inhibitory effect on angiogenesis [22], cancer cell metastasis [23], causing cell apoptosis [24], etc., it is reasonable to predict that Aspirin will be beneficial when employed as an additional alternative treatment option for cancer patients. Aspirin directly inhibits the activity of the enzyme cyclooxygenase (COX-2) and thereby impedes the synthesis of prostaglandin E2 (PGE-2), which leads to cancer cell death [25]. Recent research also suggests that Aspirin may mediate anticancer potential through COX-independent pathways such as inhibition of NFκB [26], downregulation of survivin [20], targeting AMPK-mTOR signaling [27], Wnt signaling cascade [28], etc.
A study was conducted by Dai et al. reported that Aspirin possesses antiangiogenic and anti-metastatic potential in MDA MB 23 cell line by directly binding to the enzyme heparinase. The results were further confirmed
Further inhibitory effect of TGF-β/SMAD4 signaling, as evident from decreasing the production of SMAD proteins, also contributes to the anti-metastatic potential of Aspirin [30]. In another study, Choi et al. demonstrated the effect of Aspirin in the MCF-7 cell line. It was observed that Aspirin alters the complex formation between Bcl-2 and FKBP38 and leads to the nuclear translocation of Bcl-2 and phosphorylation that causes its activation, contributing to its inhibitory effect on MCF-7 cell proliferation and also triggers apoptosis in cell lines [31]. In combination with exemestane, Aspirin showed synergy in inhibition of cell proliferation. Significant arrest in the G0/G1 phase was observed along with a more detrimental effect on COX-1 and Bcl-2 expression than individual therapy [32]. In addition, when combined with tamoxifen (which is used as a drug of choice for the estrogen receptor positive BC), it downregulates the level of cyclinD1. Subsequently, it arrests the cell cycle in phase G0/G1. In the same study, authors also reported that Aspirin inhibits the ER + ve BC cells growth and overcomes the resistance to tamoxifen in MCF-7/TAM cell line. Study demonstrated a new way to treat ER + ve BC in combination therapy of Aspirin and tamoxifen [33].
Metformin (1,1-dimethyl biguanide hydrochloride) is a well-recognized biguanide derivative and has a long history of usage in managing type 2 diabetes (T2D). Because of the outstanding ability to lower plasma glucose levels, metformin has become the primary drug for managing T2D [34]. The drug was firstly approved in 1958 in the United Kingdom, and this decade-old drug is in the WHO’s list of essential medicines [35]. Metformin belongs to the category of successful repurposed drugs and advanced into the clinical trials Phase 3/4 for its use in the prostate, oral, breast, pancreatic, and endometrial cancers [6]. Various preclinical and clinical examinations have demonstrated the effectiveness of metformin in the treatment of various malignancies such as pancreatic cancer [36], gastric cancer [37], blood cancer [38], etc. A meta-analysis study on diabetic patients with breast cancer concluded that patients who were treated with metformin and neoadjuvant therapy had a higher pathological complete response rate (24%) compared with patients not undergoing metformin treatment (8%) [39]. Another meta-analysis study demonstrated 65% survival improvement when compared with control [40]. Metformin has increased the survival opportunity in type 2 diabetic patients suffering from invasive breast cancer [41]. Study also suggested that patients on metformin demonstrate improved in the survival and response to treatment [40]. The metformin uptake is mediated by the OCT1 in BC cells [42], which is reported to play important role in the BC cells as an anticancer activity [43]. Upon entry into the cells, it leads to increase apoptosis, anti-proliferative, anti-angiogenic, which seems to be mediated by the mTOR, Akt/MAPK pathway [44]. Study conducted by Shi et al., established that metformin can also inhibit the expression of the COX-2, suggested the potential of metformin in combination with others COX-2 inhibitor [45]. Low cost and stability of metformin make it a good candidate for the treatment of cancers when compared with available treatment options [46].
Itraconazole, a triazole antifungal drug, is a well-tolerable agent that is extremely effective against a wide range of fungal infections. Itraconazole is a highly potent and effective antifungal agent due to its active metabolite, hydroxy-itraconazole, which also has significant antifungal action [47]. Itraconazole blocks ergosterol synthesis in the fungal cell membrane by inhibiting the enzyme 14α-demethylase and suppressing their growth [48]. It has emerged as a potent anticancer agent because of its ability to overcome chemoresistance prompted by P glycoproteins, altering various signaling pathways such as hedgehog (Hh) signaling cascade, Wnt/β-catenin pathway in cancer cells, and also preventing angiogenesis and lymphangiogenesis [49]. Itraconazole has been shown to have the ability to eliminate cancer cells by disrupting Hh signaling [50]. In invertebrates, the Hh signaling cascade is responsible for the regulation of complicated developmental processes. However, aberrant activation of this pathway plays a crucial role in carcinogenesis and cancer maintenance and contributes to chemoresistance, thus, targeting this pathway offers the potential therapeutic possibility [51]. Itraconazole was able to exhibit cytotoxicity in breast cancer cell lines by influencing mitochondrial membrane potential through induction of apoptosis, decreasing expression of Bcl-2, and enhancing the caspase activity. Itraconazole also promoted autophagic cell death via elevation of LC3-II expression, degradation of P62/SQSTM1, formation of autophagosomes. Hedgehog signaling is an important regulator of apoptosis and autophagy. Hence, inhibition of this signaling by Itraconazole results in cytotoxicity, tumor shrinkage, apoptosis, and autophagy in breast cancer both in
Additionally, the level of other growth factors such as fibroblast growth factor (FGF) and placenta-derived growth factor also decreased without any direct association with the Itraconazole [54]. When administered in combination with other cytotoxic agents, Itraconazole increased the response rate [55]. Researchers are trying various ways to enhance the anti-neoplastic activity of itraconazole. One such example is the development of the modified lipid nanoparticles having Miltefosine (subtherapeutic dose), called M-ITC-LNC (Membrane additive itraconazole with lipid nanoparticles (Miltefosine). The results from the cytotoxicity studies demonstrated that the anticancer activity and selectivity significantly increased in MCF-7 BC cells compared with the ITC-solution and ITC-LNC without modification [56]. In another study, itraconazole was co-delivered with the doxorubicin by liposome (coated with the Pluronic P123), resulting in the increased anti-neoplastic activity in BC [57]. The combination of the verapamil and ITC with 5-FU decreased cell survival and proliferation.
Moreover, ITC and 5-FU are more effective in the treatment of BC [58]. Administration of the Itraconazole with erlotinib (tyrosine kinase inhibitor) increased the AUC and Cmax by 10.8 and 2.78-fold, respectively, without any SAE [59]. Abovementioned all the studies reveal the potential of Itraconazole alone or in combination with other anticancer agents to treat BC.
Simvastatin belongs to the class of statins and is a well-explored hydroxy-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that reduces cholesterol biosynthesis initially used to reduce cholesterol biosynthesis marketed in 1988 [60]. Clinical data suggest that statins are effective in BC management. Statins amplify tumor cell death and radiosensitivity in various cell lines, inhibit invasion and proliferation, and show anti-metastatic activity. Clinical trials conducted on breast cancer (inflammatory and TNBC) patients also favored these observations by representing improved mortality benefits for patients on statins [61, 62]. In the same context, Simvastatin is the most explored statin to explore the role of statins in cancer. Simvastatin targets the transcription factor NFκB that reduces the expression level of anti-apoptotic protein Bcl-xL, concomitantly inhibits the expression of anti-proliferative and proapoptotic tumor suppressor PTEN and hence inhibiting the growth of breast cancer cells. The elevation of PTEN expression results in the suppression of Akt phosphorylation. Akt activity is upregulated in many cancers by increasing cancer cell survival, inhibiting apoptosis, and increasing proliferation. Therefore, Simvastatin substantially decreased Akt phosphorylation concurrently with the reduction in expression of anti-apoptotic protein by dysregulation of NFκB, thus showing the anticancer activity against BC [63]. On administration of Simvastatin, the expression of PTTG1 (pituitary tumor-transforming gene 1) was also reduced in a dose-dependent manner in the MDA-MB-231 cell line. PTTG1 is the important gene involved in the invasion and metastasis of BC [64]. In the same cell line (MDA-MB-231), Simvastatin leads to fragmentation of the cell’s nuclei, subsequently inducing apoptosis. It also enhanced the level of ROS in a dose-dependent manner, which causes oxidative stress and further DNA damage [65]. Apoptotic effects were due to the increased expression of miR-140-5p in a dose-dependent manner mediated by the activating transcription factor NRF1 [65]. Apart from the MDA-MB-231 cell line, Simvastatin effects were also explored in other breast cancer cell lines such as T47D, BT-549, and MCF-7, showing apoptotic inducer anti-proliferative activity [66, 67]. In
Simvastatin acts via blocking p50–65 leading to activation of PTEN, which inhibits PI3K-Akt axis leading to inhibition of cell growth, division, survival, migration, and proliferation.
In the same series, Sed et al. used nanoparticles made of superparamagnetic iron oxide to Simvastatin delivery with enhanced anticancer activity in the PC-3 cell line. This action is mediated by inducing apoptosis and cell cycle arrest in the G2 phase [70]. Researchers from another lab developed poly D, L-lactide-co-glycolide (PLGA) with cholic-acid-based nanoparticles for Simvastatin release in a sustained and controlled manner for breast adenocarcinoma treatment. These nanoparticles showed maintainable and more efficiently inhibit tumor growth than normal Simvastatin [71]. Other formulations such as nanocapsule [72], nanoemulsions [73], liposomes [74], and immunoliposome [75] for Simvastatin were developed with increased anticancer activity in breast cancer cells. In a randomized placebo-controlled study, Simvastatin shows a better anticancer profile with the carboplatin and vinorelbine in metastatic breast cancer [76]. Consistency in the results from both clinical and preclinical studies suggests the vast potential of Simvastatin in treating breast cancer either alone or in combination. Moreover, the development of nanoformulations also provided advantages such as enhanced cytotoxicity, lower side effects, targeted delivery over the conventional available treatment options for BC.
Niclosamide, an FDA-approved anthelminthic drug used to manage tapeworm infection, has been used almost from the last half of the century and included in the WHO’s list of essential medicines. Recent research suggests that niclosamide has a wide range of therapeutic uses other than treating parasitic infection. Niclosamide’s clinical application diseases include type 2 diabetes, endometriosis, neuropathic pain, bacterial and viral infections, including cancer [77]. The anticancer benefits of niclosamide have been shown in many malignancies such as colon cancer, lung cancer, prostate cancer in humans, as well as breast cancer by suppressing various cancer related pathways such as Wnt Notch, mTOR, STAT, and NFκB [78, 79]. The combinational treatment of niclosamide with cisplatin overcomes the resistance to cisplatin and induces an inhibitory effect on proliferation
Further, niclosamide prevented the epithelial-mesenchymal transition (EMT) by suppressing mesenchymal markers such as snail and vimentin. The inhibitory effect on EMT and prevention of stem-like phenotype of TNBC by Niclosamide operate by disabling various abnormal signaling pathways such as Akt, ERK, and Src [80]. The niclosamide acts as a potent inhibitor of STAT signaling by preventing cancer cell proliferation, invasion, and metastasis by decreasing the phosphorylation of STAT3 that otherwise was found in 35% of breast cancer tissues. Furthermore, STAT3 promotes the expression of several key downstream genes involved in proliferation, cell survival, and angiogenesis in breast cancer [81]. Human monocyte cells were reduced to HUVECs in the presence of niclosamide. Niclosamide also inhibited VCAM-1 and ICAM1 protein expression in HUVECs. Niclosamide decreased HUVEC proliferation, migration, and development of cord-like structures.
Drug | Experimental model | Mechanism of action | Observation | Original indication | References |
---|---|---|---|---|---|
Aspirin | B16F10, MDA-MB-231, MDA-MB-435 xenograft mode MCF-7, MDA-MB-231 MCF-7, MDA-MB231 | Inhibition of heparinase Inhibition of TGF-β/SMAD4 signaling pathway ↓EMT Apoptosis | ↓Metastasis, ↓angiogenesis ↓Mesenchymal markers (vimentin, Snail, TWIST) | NSIAD | [23, 30, 31] |
Itraconazole | MCF-7 and SKBR-3 breast cancer cell | Antiproliferative effect via inhibition of hedgehog signaling cascade ↑Apoptosis ↑Autophagy ↑Cell cycle arrest | ↓Tumor size ↑Caspase 3 ↓Bcl-2 | Antifungal drug | [50] |
Niclosamide | ↓EM T ↑Apoptosis Inhibition of stat signaling | ↓Snail ↓Vimentin ↓Tumor growth ↑Caspase 3, ↓Bcl-2, ↓surviving, ↓Mcl-1 expression | Anthelminthic drug | [80, 81] | |
Simvastatin | MDA-MB-231, T47D, BT-549 and MCF-7 ( DMBA model ( | ↓PTTG1, ↓Bcl-xL ↑ROS ↑miR-140-5p Inhibition of Akt and DNA damage | Anti-proliferative, induce apoptosis, and increased survival | Anti-hypercholesterolemic drug | [63, 64, 65, 66, 67] |
Metformin | MDA-MB-231, MCF-7 | Via mTOR, Akt/MAPK pathway COX-2 inhibition | Apoptosis, anti-proliferative, anti-angiogenic | Anti-diabetic drug | [44, 45] |
Summary of the repurposed drugs for BC discussed in the chapter.
Drug discovery is a multifaceted process that aims at identifying a therapeutic agent that can be useful in treating and managing various ailments. This process includes identification of candidates, characterization, validation, optimization, screening, and assays for therapeutic effectiveness. As the mortality due to cancer is progressively increasing, we need effective therapy to treat breast cancer patients or improve survival. When any pharmaceutical organization starts developing a novel chemical entity for the BC, its cost and attrition rate are very high. Drugs repurposing is how we can minimize the cost and attrition rate by using the already marketed drugs for a new use. Drug repurposing against breast cancer is one of the best alternatives to treat progressive ailments. In the above discussion, we have discussed various drugs that can be repurposed against breast cancer. It will be a game-changing scenario in the treatment of breast cancer. Certain challenges need to be rectified. However, there is a need for optimization of models and more screening of drugs at preclinical stages.
To tackle all the challenges associated with the drug development process for breast cancer, scientists need to shift their interest to the alternative drug development, that is, drug repurposing. All the BC repurposed drugs discussed in the book chapter show impressive results that suggest exploring more new non-cancerous drugs for cancerous use [92]. Using the drugs repurposing approaches alone and in combination with other drugs will also reduce the side effects associated with high doses. It will also reduce the cost of the drug development process, ultimately patient compliances and burden. Patients who could not afford the treatment due to the high cost can take treatment and improve survival. As the safety is already studied of drugs that seem a novel interest in the repurposing for BC, the chances of failure at the clinical level will also be less. With the advancement in drug repurposing, there is still a need to develop a valuable model of different types of cancers that mimic cancer. The development of such a model provides the actual clue for drug repurposing. So far, the advantages we discussed, there are some challenges associated with the drugs repurposing such as patent issue, regulatory consideration, inequitable prescription that need to be overcome so, more and more pharma companies show their interest in drug repurposing. It is expected that drug repurposing will achieve the milestone that is currently not possible with the conventional available treatment for cancers in the future. Furthermore, new nanoformulations need to be developed for the targeted and specific delivery of repurposed anticancer drug to avoid the off-target side effects.
Book - collection of Works distributed in a book format, whose selection, coordination, preparation, and arrangement has been performed and published by IntechOpen, and in which the Work is included in its entirety in an unmodified form along with one or more other contributions, each constituting separate and independent sections, but together assembled into a collective whole.
",metaTitle:"Attribution Policy",metaDescription:"DEFINITION OF TERMS",metaKeywords:null,canonicalURL:"/page/attribution-policy",contentRaw:'[{"type":"htmlEditorComponent","content":"Work - a book Chapter (as well as Conference Papers), including any and all content, graphics, images and/or other materials forming part of, or accompanying, the Chapter/Conference Paper.
\\n\\nAttribution – appropriate credit for the used Work or book.
\\n\\nCreative Commons licenses – enable licensors to retain copyright while allowing others to use their Works in an appropriate way.
\\n\\nWith the purpose of protecting Authors' copyright and the transparent reuse of OA (Open Access) content, IntechOpen has developed Rules of Attribution of Works licensed under Creative Commons licenses.
\\n\\nIn case you reuse or republish any of the Works licensed under CC licenses, you must abide by the guidelines outlined below:
\\n\\nAll rights to Books and other compilations published on the IntechOpen platform and in print are reserved by IntechOpen. The Copyright to Books and other compilations is subject to a separate Copyright from any that exists in the included Works.
\\n\\nA Book in its entirety or a significant part of a Book cannot be translated freely without specific written consent by the publisher. Further information can be obtained at permissions@intechopen.com.
\\n\\nIn instances where permission is obtained from the publisher for reusing or republishing the Book, or significant parts of the Book, all of the following conditions apply:
\\n\\nEvery single Work that is used has to be attributed in the way described. If you are unsure about proper attribution, please write to permissions@intechopen.com.
\\n\\nIndividual Works originally published in IntechOpen books are licensed under Creative Commons licenses and can be freely used under terms of the respective CC license, if properly attributed. In order to properly attribute the Work you must respect all the conditions outlined below:
\\n\\nEvery single Work that is used has to be attributed in the way as described. If you are unsure about proper attribution, please contact Us at permissions@intechopen.com.
\\n\\nIn the event that you use more than one of IntechOpen's Works published in one or more books (but not a significant part of the book that is under separate Copyright), each of these have to be properly attributed in the way described.
\\n\\nIntechOpen does not have any claims on newly created copyrighted Works, but the Works originally published by IntechOpen must be properly attributed.
\\n\\nAll these rules apply to BOTH online and offline use.
\\n\\nParts of the Rules of Attribution are based on Work Attributing Creative Commons Materials published by the Australian Research Council Centre of Excellence for Creative Industries and Innovation, in partnership with Creative Commons Australia, which can be found at creativecommons.org.au licensed under Creative Commons Attribution 2.5 Australia license, and Best practices for attribution published by Creative Commons, which can be found at wiki.creativecommons.org under the Creative Commons Attribution 4.0 license.
\\n\\nAll the above rules are subject to change, IntechOpen reserves the right to take appropriate action if any of the conditions outlined above are not met.
\\n\\nPolicy last updated: 2016-06-09
\\n"}]'},components:[{type:"htmlEditorComponent",content:'Work - a book Chapter (as well as Conference Papers), including any and all content, graphics, images and/or other materials forming part of, or accompanying, the Chapter/Conference Paper.
\n\nAttribution – appropriate credit for the used Work or book.
\n\nCreative Commons licenses – enable licensors to retain copyright while allowing others to use their Works in an appropriate way.
\n\nWith the purpose of protecting Authors' copyright and the transparent reuse of OA (Open Access) content, IntechOpen has developed Rules of Attribution of Works licensed under Creative Commons licenses.
\n\nIn case you reuse or republish any of the Works licensed under CC licenses, you must abide by the guidelines outlined below:
\n\nAll rights to Books and other compilations published on the IntechOpen platform and in print are reserved by IntechOpen. The Copyright to Books and other compilations is subject to a separate Copyright from any that exists in the included Works.
\n\nA Book in its entirety or a significant part of a Book cannot be translated freely without specific written consent by the publisher. Further information can be obtained at permissions@intechopen.com.
\n\nIn instances where permission is obtained from the publisher for reusing or republishing the Book, or significant parts of the Book, all of the following conditions apply:
\n\nEvery single Work that is used has to be attributed in the way described. If you are unsure about proper attribution, please write to permissions@intechopen.com.
\n\nIndividual Works originally published in IntechOpen books are licensed under Creative Commons licenses and can be freely used under terms of the respective CC license, if properly attributed. In order to properly attribute the Work you must respect all the conditions outlined below:
\n\nEvery single Work that is used has to be attributed in the way as described. If you are unsure about proper attribution, please contact Us at permissions@intechopen.com.
\n\nIn the event that you use more than one of IntechOpen's Works published in one or more books (but not a significant part of the book that is under separate Copyright), each of these have to be properly attributed in the way described.
\n\nIntechOpen does not have any claims on newly created copyrighted Works, but the Works originally published by IntechOpen must be properly attributed.
\n\nAll these rules apply to BOTH online and offline use.
\n\nParts of the Rules of Attribution are based on Work Attributing Creative Commons Materials published by the Australian Research Council Centre of Excellence for Creative Industries and Innovation, in partnership with Creative Commons Australia, which can be found at creativecommons.org.au licensed under Creative Commons Attribution 2.5 Australia license, and Best practices for attribution published by Creative Commons, which can be found at wiki.creativecommons.org under the Creative Commons Attribution 4.0 license.
\n\nAll the above rules are subject to change, IntechOpen reserves the right to take appropriate action if any of the conditions outlined above are not met.
\n\nPolicy last updated: 2016-06-09
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"396",title:"Dr.",name:"Vedran",middleName:null,surname:"Kordic",slug:"vedran-kordic",fullName:"Vedran Kordic",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/396/images/7281_n.png",biography:"After obtaining his Master's degree in Mechanical Engineering he continued his education at the Vienna University of Technology where he obtained his PhD degree in 2004. He worked as a researcher at the Automation and Control Institute, Faculty of Electrical Engineering, Vienna University of Technology until 2008. His studies in robotics lead him not only to a PhD degree but also inspired him to co-found and build the International Journal of Advanced Robotic Systems - world's first Open Access journal in the field of robotics.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"441",title:"Ph.D.",name:"Jaekyu",middleName:null,surname:"Park",slug:"jaekyu-park",fullName:"Jaekyu Park",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/441/images/1881_n.jpg",biography:null,institutionString:null,institution:{name:"LG Corporation (South Korea)",country:{name:"Korea, South"}}},{id:"465",title:"Dr.",name:"Christian",middleName:null,surname:"Martens",slug:"christian-martens",fullName:"Christian Martens",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Rheinmetall (Germany)",country:{name:"Germany"}}},{id:"479",title:"Dr.",name:"Valentina",middleName:null,surname:"Colla",slug:"valentina-colla",fullName:"Valentina Colla",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/479/images/358_n.jpg",biography:null,institutionString:null,institution:{name:"Sant'Anna School of Advanced Studies",country:{name:"Italy"}}},{id:"494",title:"PhD",name:"Loris",middleName:null,surname:"Nanni",slug:"loris-nanni",fullName:"Loris Nanni",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/494/images/system/494.jpg",biography:"Loris Nanni received his Master Degree cum laude on June-2002 from the University of Bologna, and the April 26th 2006 he received his Ph.D. in Computer Engineering at DEIS, University of Bologna. On September, 29th 2006 he has won a post PhD fellowship from the university of Bologna (from October 2006 to October 2008), at the competitive examination he was ranked first in the industrial engineering area. He extensively served as referee for several international journals. He is author/coauthor of more than 100 research papers. He has been involved in some projects supported by MURST and European Community. His research interests include pattern recognition, bioinformatics, and biometric systems (fingerprint classification and recognition, signature verification, face recognition).",institutionString:null,institution:null},{id:"496",title:"Dr.",name:"Carlos",middleName:null,surname:"Leon",slug:"carlos-leon",fullName:"Carlos Leon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Seville",country:{name:"Spain"}}},{id:"512",title:"Dr.",name:"Dayang",middleName:null,surname:"Jawawi",slug:"dayang-jawawi",fullName:"Dayang Jawawi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"528",title:"Dr.",name:"Kresimir",middleName:null,surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/528/images/system/528.jpg",biography:"K. Delac received his B.Sc.E.E. degree in 2003 and is currentlypursuing a Ph.D. degree at the University of Zagreb, Faculty of Electrical Engineering andComputing. His current research interests are digital image analysis, pattern recognition andbiometrics.",institutionString:null,institution:{name:"University of Zagreb",country:{name:"Croatia"}}},{id:"557",title:"Dr.",name:"Andon",middleName:"Venelinov",surname:"Topalov",slug:"andon-topalov",fullName:"Andon Topalov",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/557/images/1927_n.jpg",biography:"Dr. Andon V. Topalov received the MSc degree in Control Engineering from the Faculty of Information Systems, Technologies, and Automation at Moscow State University of Civil Engineering (MGGU) in 1979. He then received his PhD degree in Control Engineering from the Department of Automation and Remote Control at Moscow State Mining University (MGSU), Moscow, in 1984. From 1985 to 1986, he was a Research Fellow in the Research Institute for Electronic Equipment, ZZU AD, Plovdiv, Bulgaria. In 1986, he joined the Department of Control Systems, Technical University of Sofia at the Plovdiv campus, where he is presently a Full Professor. He has held long-term visiting Professor/Scholar positions at various institutions in South Korea, Turkey, Mexico, Greece, Belgium, UK, and Germany. And he has coauthored one book and authored or coauthored more than 80 research papers in conference proceedings and journals. His current research interests are in the fields of intelligent control and robotics.",institutionString:null,institution:{name:"Technical University of Sofia",country:{name:"Bulgaria"}}},{id:"585",title:"Prof.",name:"Munir",middleName:null,surname:"Merdan",slug:"munir-merdan",fullName:"Munir Merdan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/585/images/system/585.jpg",biography:"Munir Merdan received the M.Sc. degree in mechanical engineering from the Technical University of Sarajevo, Bosnia and Herzegovina, in 2001, and the Ph.D. degree in electrical engineering from the Vienna University of Technology, Vienna, Austria, in 2009.Since 2005, he has been at the Automation and Control Institute, Vienna University of Technology, where he is currently a Senior Researcher. His research interests include the application of agent technology for achieving agile control in the manufacturing environment.",institutionString:null,institution:null},{id:"605",title:"Prof",name:"Dil",middleName:null,surname:"Hussain",slug:"dil-hussain",fullName:"Dil Hussain",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/605/images/system/605.jpg",biography:"Dr. Dil Muhammad Akbar Hussain is a professor of Electronics Engineering & Computer Science at the Department of Energy Technology, Aalborg University Denmark. Professor Akbar has a Master degree in Digital Electronics from Govt. College University, Lahore Pakistan and a P-hD degree in Control Engineering from the School of Engineering and Applied Sciences, University of Sussex United Kingdom. Aalborg University has Two Satellite Campuses, one in Copenhagen (Aalborg University Copenhagen) and the other in Esbjerg (Aalborg University Esbjerg).\n· He is a member of prestigious IEEE (Institute of Electrical and Electronics Engineers), and IAENG (International Association of Engineers) organizations. \n· He is the chief Editor of the Journal of Software Engineering.\n· He is the member of the Editorial Board of International Journal of Computer Science and Software Technology (IJCSST) and International Journal of Computer Engineering and Information Technology. \n· He is also the Editor of Communication in Computer and Information Science CCIS-20 by Springer.\n· Reviewer For Many Conferences\nHe is the lead person in making collaboration agreements between Aalborg University and many universities of Pakistan, for which the MOU’s (Memorandum of Understanding) have been signed.\nProfessor Akbar is working in Academia since 1990, he started his career as a Lab demonstrator/TA at the University of Sussex. After finishing his P. hD degree in 1992, he served in the Industry as a Scientific Officer and continued his academic career as a visiting scholar for a number of educational institutions. In 1996 he joined National University of Science & Technology Pakistan (NUST) as an Associate Professor; NUST is one of the top few universities in Pakistan. In 1999 he joined an International Company Lineo Inc, Canada as Manager Compiler Group, where he headed the group for developing Compiler Tool Chain and Porting of Operating Systems for the BLACKfin processor. The processor development was a joint venture by Intel and Analog Devices. In 2002 Lineo Inc., was taken over by another company, so he joined Aalborg University Denmark as an Assistant Professor.\nProfessor Akbar has truly a multi-disciplined career and he continued his legacy and making progress in many areas of his interests both in teaching and research. He has contributed in stochastic estimation of control area especially, in the Multiple Target Tracking and Interactive Multiple Model (IMM) research, Ball & Beam Control Problem, Robotics, Levitation Control. He has contributed in developing Algorithms for Fingerprint Matching, Computer Vision and Face Recognition. He has been supervising Pattern Recognition, Formal Languages and Distributed Processing projects for several years. He has reviewed many books on Management, Computer Science. Currently, he is an active and permanent reviewer for many international conferences and symposia and the program committee member for many international conferences.\nIn teaching he has taught the core computer science subjects like, Digital Design, Real Time Embedded System Programming, Operating Systems, Software Engineering, Data Structures, Databases, Compiler Construction. In the Engineering side, Digital Signal Processing, Computer Architecture, Electronics Devices, Digital Filtering and Engineering Management.\nApart from his Academic Interest and activities he loves sport especially, Cricket, Football, Snooker and Squash. He plays cricket for Esbjerg city in the second division team as an opener wicket keeper batsman. He is a very good player of squash but has not played squash since his arrival in Denmark.",institutionString:null,institution:null},{id:"611",title:"Prof.",name:"T",middleName:null,surname:"Nagarajan",slug:"t-nagarajan",fullName:"T Nagarajan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Teknologi Petronas",country:{name:"Malaysia"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:8616},{group:"region",caption:"Middle and South America",value:2,count:7693},{group:"region",caption:"Africa",value:3,count:3005},{group:"region",caption:"Asia",value:4,count:15646},{group:"region",caption:"Australia and Oceania",value:5,count:1284},{group:"region",caption:"Europe",value:6,count:22554}],offset:12,limit:12,total:134466},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"0",sort:"-dateEndThirdStepPublish",src:"C-F-0"},books:[{type:"book",id:"9985",title:"Geostatistics",subtitle:null,isOpenForSubmission:!0,hash:"423cb3896195a618c4acb493ce4fd23d",slug:null,bookSignature:"Prof. Jeffrey M. Yarus, Dr. Marko Maucec, Dr. Timothy C. Coburn and Associate Prof. Michael Pyrcz",coverURL:"https://cdn.intechopen.com/books/images_new/9985.jpg",editedByType:null,editors:[{id:"78011",title:"Prof.",name:"Jeffrey M.",surname:"Yarus",slug:"jeffrey-m.-yarus",fullName:"Jeffrey M. Yarus"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12058",title:"Future Housing",subtitle:null,isOpenForSubmission:!0,hash:"e7f4a1e57fab392b61156956c1247b9e",slug:null,bookSignature:"Dr. Ivan Oropeza-Perez and Dr. Astrid Helena Petzold-Rodríguez",coverURL:"https://cdn.intechopen.com/books/images_new/12058.jpg",editedByType:null,editors:[{id:"282172",title:"Dr.",name:"Ivan",surname:"Oropeza-Perez",slug:"ivan-oropeza-perez",fullName:"Ivan Oropeza-Perez"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12215",title:"Cell Death and Disease",subtitle:null,isOpenForSubmission:!0,hash:"dfd456a29478fccf4ebd3294137eb1e3",slug:null,bookSignature:"Dr. Ke Xu",coverURL:"https://cdn.intechopen.com/books/images_new/12215.jpg",editedByType:null,editors:[{id:"59529",title:"Dr.",name:"Ke",surname:"Xu",slug:"ke-xu",fullName:"Ke Xu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12112",title:"The Colorectal Surgery",subtitle:null,isOpenForSubmission:!0,hash:"21c65e742d31d5b69fb681ef78cfa0be",slug:null,bookSignature:"Dr. Muhammad Shamim",coverURL:"https://cdn.intechopen.com/books/images_new/12112.jpg",editedByType:null,editors:[{id:"235128",title:"Dr.",name:"Muhammad",surname:"Shamim",slug:"muhammad-shamim",fullName:"Muhammad Shamim"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11998",title:"Biocomposites - Recent Advances",subtitle:null,isOpenForSubmission:!0,hash:"8bc7ffd7544fff1901301c787e64fada",slug:null,bookSignature:"Prof. Magdy Elnashar",coverURL:"https://cdn.intechopen.com/books/images_new/11998.jpg",editedByType:null,editors:[{id:"12075",title:"Prof.",name:"Magdy",surname:"Elnashar",slug:"magdy-elnashar",fullName:"Magdy Elnashar"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12079",title:"Strategies Towards the Synthesis of Heterocycles and Their Applications",subtitle:null,isOpenForSubmission:!0,hash:"bc4022af925c0883636e0819008971ee",slug:null,bookSignature:"Dr. Premlata Kumari and Dr. Amit B Patel",coverURL:"https://cdn.intechopen.com/books/images_new/12079.jpg",editedByType:null,editors:[{id:"177041",title:"Dr.",name:"Premlata",surname:"Kumari",slug:"premlata-kumari",fullName:"Premlata Kumari"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11999",title:"Earthquakes - Recent Advances, New Perspectives and Applications",subtitle:null,isOpenForSubmission:!0,hash:"b2af07109b13b76e5af9583532ab5bee",slug:null,bookSignature:"Dr. Walter Salazar",coverURL:"https://cdn.intechopen.com/books/images_new/11999.jpg",editedByType:null,editors:[{id:"236461",title:"Dr.",name:"Walter",surname:"Salazar",slug:"walter-salazar",fullName:"Walter Salazar"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12208",title:"Metformin - A Prospective Alternative for the Treatment of Chronic Diseases",subtitle:null,isOpenForSubmission:!0,hash:"aa4b8aac3f44ba3ab334530c5d5646ea",slug:null,bookSignature:"Prof. Farid A. Badria",coverURL:"https://cdn.intechopen.com/books/images_new/12208.jpg",editedByType:null,editors:[{id:"41865",title:"Prof.",name:"Farid A.",surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12172",title:"Health Risks of Food Additives - Recent Developments and Trends in Food Sector",subtitle:null,isOpenForSubmission:!0,hash:"f6aa23b1045d266d0928fcef04fa3417",slug:null,bookSignature:"Dr. Muhammad Sajid Arshad and Mr. Waseem Khalid",coverURL:"https://cdn.intechopen.com/books/images_new/12172.jpg",editedByType:null,editors:[{id:"192998",title:"Dr.",name:"Muhammad Sajid",surname:"Arshad",slug:"muhammad-sajid-arshad",fullName:"Muhammad Sajid Arshad"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12113",title:"Tendons - Trauma, Inflammation, Degeneration, and Treatment",subtitle:null,isOpenForSubmission:!0,hash:"2387a4e0d2a76883b16dcccd452281ab",slug:null,bookSignature:"Dr. Nahum Rosenberg",coverURL:"https://cdn.intechopen.com/books/images_new/12113.jpg",editedByType:null,editors:[{id:"68911",title:"Dr.",name:"Nahum",surname:"Rosenberg",slug:"nahum-rosenberg",fullName:"Nahum Rosenberg"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11500",title:"Multi-Objective Optimization - Recent Advances, New Perspectives and Applications",subtitle:null,isOpenForSubmission:!0,hash:"842f84f308439c0a55c4e8e6a8fd9c01",slug:null,bookSignature:"Dr. Adel El-Shahat",coverURL:"https://cdn.intechopen.com/books/images_new/11500.jpg",editedByType:null,editors:[{id:"193331",title:"Dr.",name:"Adel",surname:"El-Shahat",slug:"adel-el-shahat",fullName:"Adel El-Shahat"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12196",title:"Sepsis - New Perspectives",subtitle:null,isOpenForSubmission:!0,hash:"3590e6f6047122bd96d1d57da29c4054",slug:null,bookSignature:"Dr. Lixing Huang, Dr. Youyu Zhang and Dr. Lingbin Sun",coverURL:"https://cdn.intechopen.com/books/images_new/12196.jpg",editedByType:null,editors:[{id:"333148",title:"Dr.",name:"Lixing",surname:"Huang",slug:"lixing-huang",fullName:"Lixing Huang"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:36},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:11},{group:"topic",caption:"Business, Management and Economics",value:7,count:7},{group:"topic",caption:"Chemistry",value:8,count:22},{group:"topic",caption:"Computer and Information Science",value:9,count:23},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:15},{group:"topic",caption:"Engineering",value:11,count:61},{group:"topic",caption:"Environmental Sciences",value:12,count:9},{group:"topic",caption:"Immunology and Microbiology",value:13,count:14},{group:"topic",caption:"Materials Science",value:14,count:23},{group:"topic",caption:"Mathematics",value:15,count:11},{group:"topic",caption:"Medicine",value:16,count:106},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:6},{group:"topic",caption:"Neuroscience",value:18,count:3},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:9},{group:"topic",caption:"Physics",value:20,count:9},{group:"topic",caption:"Psychology",value:21,count:9},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:9},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:3}],offset:12,limit:12,total:389},popularBooks:{featuredBooks:[{type:"book",id:"10858",title:"MOOC (Massive Open Online Courses)",subtitle:null,isOpenForSubmission:!1,hash:"d32f86793bc72dde32532f509b1ec5b0",slug:"mooc-massive-open-online-courses-",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/10858.jpg",editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10195",title:"Serotonin and the CNS",subtitle:"New Developments in Pharmacology and Therapeutics",isOpenForSubmission:!1,hash:"7ed9d96da98233a885bd2869a8056c36",slug:"serotonin-and-the-cns-new-developments-in-pharmacology-and-therapeutics",bookSignature:"Berend Olivier",coverURL:"https://cdn.intechopen.com/books/images_new/10195.jpg",editors:[{id:"71579",title:"Prof.",name:"Berend",middleName:null,surname:"Olivier",slug:"berend-olivier",fullName:"Berend Olivier"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10755",title:"Corporate Governance",subtitle:"Recent Advances and Perspectives",isOpenForSubmission:!1,hash:"ffe06d1d5c4bf0fc2e63511825fe1257",slug:"corporate-governance-recent-advances-and-perspectives",bookSignature:"Okechukwu Lawrence Emeagwali and Feyza Bhatti",coverURL:"https://cdn.intechopen.com/books/images_new/10755.jpg",editors:[{id:"196317",title:"Associate Prof.",name:"Okechukwu Lawrence",middleName:null,surname:"Emeagwali",slug:"okechukwu-lawrence-emeagwali",fullName:"Okechukwu Lawrence Emeagwali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11120",title:"Environmental Impact and Remediation of Heavy Metals",subtitle:null,isOpenForSubmission:!1,hash:"9e77514288e7394f1e6cd13481af3509",slug:"environmental-impact-and-remediation-of-heavy-metals",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11120.jpg",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10901",title:"Grapes and Wine",subtitle:null,isOpenForSubmission:!1,hash:"5d7f2aa74874444bc6986e613ccebd7c",slug:"grapes-and-wine",bookSignature:"Antonio Morata, Iris Loira and Carmen González",coverURL:"https://cdn.intechopen.com/books/images_new/10901.jpg",editors:[{id:"180952",title:"Prof.",name:"Antonio",middleName:null,surname:"Morata",slug:"antonio-morata",fullName:"Antonio Morata"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11080",title:"Engineering Principles",subtitle:"Welding and Residual Stresses",isOpenForSubmission:!1,hash:"6c07a13a113bce94174b40096f30fb5e",slug:"engineering-principles-welding-and-residual-stresses",bookSignature:"Kavian Omar Cooke and Ronaldo Câmara Cozza",coverURL:"https://cdn.intechopen.com/books/images_new/11080.jpg",editors:[{id:"138778",title:"Dr.",name:"Kavian",middleName:"Omar",surname:"Cooke",slug:"kavian-cooke",fullName:"Kavian Cooke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",isOpenForSubmission:!1,hash:"742e6cae3a35686f975edc8d7f9afa94",slug:"essential-oils-advances-in-extractions-and-biological-applications",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11029",title:"Hepatitis B",subtitle:null,isOpenForSubmission:!1,hash:"609701f502efc3538c112ff47a2c2119",slug:"hepatitis-b",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/11029.jpg",editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9537",title:"Human Rights in the Contemporary World",subtitle:null,isOpenForSubmission:!1,hash:"54f05b93812fd434f3962956d6413a6b",slug:"human-rights-in-the-contemporary-world",bookSignature:"Trudy Corrigan",coverURL:"https://cdn.intechopen.com/books/images_new/9537.jpg",editors:[{id:"197557",title:"Dr.",name:"Trudy",middleName:null,surname:"Corrigan",slug:"trudy-corrigan",fullName:"Trudy Corrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11371",title:"Cerebral Circulation",subtitle:"Updates on Models, Diagnostics and Treatments of Related Diseases",isOpenForSubmission:!1,hash:"e2d3335445d2852d0b906bb9750e939f",slug:"cerebral-circulation-updates-on-models-diagnostics-and-treatments-of-related-diseases",bookSignature:"Alba Scerrati, Luca Ricciardi and Flavia Dones",coverURL:"https://cdn.intechopen.com/books/images_new/11371.jpg",editors:[{id:"182614",title:"Dr.",name:"Alba",middleName:null,surname:"Scerrati",slug:"alba-scerrati",fullName:"Alba Scerrati"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11012",title:"Radiopharmaceuticals",subtitle:"Current Research for Better Diagnosis and Therapy",isOpenForSubmission:!1,hash:"f9046d6f96148b285e776f384991120d",slug:"radiopharmaceuticals-current-research-for-better-diagnosis-and-therapy",bookSignature:"Farid A. Badria",coverURL:"https://cdn.intechopen.com/books/images_new/11012.jpg",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9974",title:"E-Learning and Digital Education in the Twenty-First Century",subtitle:null,isOpenForSubmission:!1,hash:"88b58d66e975df20425fc1dfd22d53aa",slug:"e-learning-and-digital-education-in-the-twenty-first-century",bookSignature:"M. Mahruf C. Shohel",coverURL:"https://cdn.intechopen.com/books/images_new/9974.jpg",editors:[{id:"94099",title:"Dr.",name:"M. Mahruf C.",middleName:null,surname:"Shohel",slug:"m.-mahruf-c.-shohel",fullName:"M. Mahruf C. Shohel"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4438},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10858",title:"MOOC (Massive Open Online Courses)",subtitle:null,isOpenForSubmission:!1,hash:"d32f86793bc72dde32532f509b1ec5b0",slug:"mooc-massive-open-online-courses-",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/10858.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1677,editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10195",title:"Serotonin and the CNS",subtitle:"New Developments in Pharmacology and Therapeutics",isOpenForSubmission:!1,hash:"7ed9d96da98233a885bd2869a8056c36",slug:"serotonin-and-the-cns-new-developments-in-pharmacology-and-therapeutics",bookSignature:"Berend Olivier",coverURL:"https://cdn.intechopen.com/books/images_new/10195.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1337,editors:[{id:"71579",title:"Prof.",name:"Berend",middleName:null,surname:"Olivier",slug:"berend-olivier",fullName:"Berend Olivier"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10755",title:"Corporate Governance",subtitle:"Recent Advances and Perspectives",isOpenForSubmission:!1,hash:"ffe06d1d5c4bf0fc2e63511825fe1257",slug:"corporate-governance-recent-advances-and-perspectives",bookSignature:"Okechukwu Lawrence Emeagwali and Feyza Bhatti",coverURL:"https://cdn.intechopen.com/books/images_new/10755.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1309,editors:[{id:"196317",title:"Associate Prof.",name:"Okechukwu Lawrence",middleName:null,surname:"Emeagwali",slug:"okechukwu-lawrence-emeagwali",fullName:"Okechukwu Lawrence Emeagwali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11120",title:"Environmental Impact and Remediation of Heavy Metals",subtitle:null,isOpenForSubmission:!1,hash:"9e77514288e7394f1e6cd13481af3509",slug:"environmental-impact-and-remediation-of-heavy-metals",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11120.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:847,editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10901",title:"Grapes and Wine",subtitle:null,isOpenForSubmission:!1,hash:"5d7f2aa74874444bc6986e613ccebd7c",slug:"grapes-and-wine",bookSignature:"Antonio Morata, Iris Loira and Carmen González",coverURL:"https://cdn.intechopen.com/books/images_new/10901.jpg",publishedDate:"June 15th 2022",numberOfDownloads:2273,editors:[{id:"180952",title:"Prof.",name:"Antonio",middleName:null,surname:"Morata",slug:"antonio-morata",fullName:"Antonio Morata"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11080",title:"Engineering Principles",subtitle:"Welding and Residual Stresses",isOpenForSubmission:!1,hash:"6c07a13a113bce94174b40096f30fb5e",slug:"engineering-principles-welding-and-residual-stresses",bookSignature:"Kavian Omar Cooke and Ronaldo Câmara Cozza",coverURL:"https://cdn.intechopen.com/books/images_new/11080.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:591,editors:[{id:"138778",title:"Dr.",name:"Kavian",middleName:"Omar",surname:"Cooke",slug:"kavian-cooke",fullName:"Kavian Cooke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",isOpenForSubmission:!1,hash:"742e6cae3a35686f975edc8d7f9afa94",slug:"essential-oils-advances-in-extractions-and-biological-applications",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:515,editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11029",title:"Hepatitis B",subtitle:null,isOpenForSubmission:!1,hash:"609701f502efc3538c112ff47a2c2119",slug:"hepatitis-b",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/11029.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:413,editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9537",title:"Human Rights in the Contemporary World",subtitle:null,isOpenForSubmission:!1,hash:"54f05b93812fd434f3962956d6413a6b",slug:"human-rights-in-the-contemporary-world",bookSignature:"Trudy Corrigan",coverURL:"https://cdn.intechopen.com/books/images_new/9537.jpg",publishedDate:"June 8th 2022",numberOfDownloads:2194,editors:[{id:"197557",title:"Dr.",name:"Trudy",middleName:null,surname:"Corrigan",slug:"trudy-corrigan",fullName:"Trudy Corrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11371",title:"Cerebral Circulation",subtitle:"Updates on Models, Diagnostics and Treatments of Related Diseases",isOpenForSubmission:!1,hash:"e2d3335445d2852d0b906bb9750e939f",slug:"cerebral-circulation-updates-on-models-diagnostics-and-treatments-of-related-diseases",bookSignature:"Alba Scerrati, Luca Ricciardi and Flavia Dones",coverURL:"https://cdn.intechopen.com/books/images_new/11371.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:341,editors:[{id:"182614",title:"Dr.",name:"Alba",middleName:null,surname:"Scerrati",slug:"alba-scerrati",fullName:"Alba Scerrati"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"11042",title:"Complementary Therapies",subtitle:null,isOpenForSubmission:!1,hash:"9eb32ccbef95289a133a76e5808a525b",slug:"complementary-therapies",bookSignature:"Mario Bernardo-Filho, Redha Taiar, Danúbia da Cunha de Sá-Caputo and Adérito Seixas",coverURL:"https://cdn.intechopen.com/books/images_new/11042.jpg",editedByType:"Edited by",publishedDate:"July 6th 2022",editors:[{id:"157376",title:"Prof.",name:"Mario",middleName:null,surname:"Bernardo-Filho",slug:"mario-bernardo-filho",fullName:"Mario Bernardo-Filho"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10037",title:"Thermoelectricity",subtitle:"Recent Advances, New Perspectives and Applications",isOpenForSubmission:!1,hash:"ad1d3f637564a29cf1636759f5401994",slug:"thermoelectricity-recent-advances-new-perspectives-and-applications",bookSignature:"Guangzhao Qin",coverURL:"https://cdn.intechopen.com/books/images_new/10037.jpg",editedByType:"Edited by",publishedDate:"July 6th 2022",editors:[{id:"188870",title:"Mr.",name:"Guangzhao",middleName:null,surname:"Qin",slug:"guangzhao-qin",fullName:"Guangzhao Qin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11357",title:"Sustainable Crop Production",subtitle:"Recent Advances",isOpenForSubmission:!1,hash:"ee41e09e4ad6a336ca9f0e5462da3904",slug:"sustainable-crop-production-recent-advances",bookSignature:"Vijay Singh Meena, Mahipal Choudhary, Ram Prakash Yadav and Sunita Kumari Meena",coverURL:"https://cdn.intechopen.com/books/images_new/11357.jpg",editedByType:"Edited by",publishedDate:"July 6th 2022",editors:[{id:"420235",title:"Dr.",name:"Vijay",middleName:null,surname:"Meena",slug:"vijay-meena",fullName:"Vijay Meena"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10863",title:"Cardiac Rhythm Management",subtitle:"Pacing, Ablation, Devices",isOpenForSubmission:!1,hash:"a064ec49b85ebfc60585c9c3690af53a",slug:"cardiac-rhythm-management-pacing-ablation-devices",bookSignature:"Mart Min and Gabriel Cismaru",coverURL:"https://cdn.intechopen.com/books/images_new/10863.jpg",editedByType:"Edited by",publishedDate:"July 6th 2022",editors:[{id:"62780",title:"Prof.",name:"Mart",middleName:null,surname:"Min",slug:"mart-min",fullName:"Mart Min"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10874",title:"Insights on Antimicrobial Peptides",subtitle:null,isOpenForSubmission:!1,hash:"23ca26025e87356a7c2ffac365f73a22",slug:"insights-on-antimicrobial-peptides",bookSignature:"Shymaa Enany, Jorge Masso-Silva and Anna Savitskaya",coverURL:"https://cdn.intechopen.com/books/images_new/10874.jpg",editedByType:"Edited by",publishedDate:"July 6th 2022",editors:[{id:"81926",title:"Dr.",name:"Shymaa",middleName:null,surname:"Enany",slug:"shymaa-enany",fullName:"Shymaa Enany"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11137",title:"Mineralogy",subtitle:null,isOpenForSubmission:!1,hash:"e0e4727c9f1f9b34d788f0dc70278f2b",slug:"mineralogy",bookSignature:"Miloš René",coverURL:"https://cdn.intechopen.com/books/images_new/11137.jpg",editedByType:"Edited by",publishedDate:"July 6th 2022",editors:[{id:"142108",title:"Dr.",name:"Miloš",middleName:null,surname:"René",slug:"milos-rene",fullName:"Miloš René"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10882",title:"Smart Drug Delivery",subtitle:null,isOpenForSubmission:!1,hash:"70c3ce4256324b3c58db970d446ddac4",slug:"smart-drug-delivery",bookSignature:"Usama Ahmad, Md. Faheem Haider and Juber Akhtar",coverURL:"https://cdn.intechopen.com/books/images_new/10882.jpg",editedByType:"Edited by",publishedDate:"July 6th 2022",editors:[{id:"255360",title:"Dr.",name:"Usama",middleName:null,surname:"Ahmad",slug:"usama-ahmad",fullName:"Usama Ahmad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10885",title:"Snake Venom and Ecology",subtitle:null,isOpenForSubmission:!1,hash:"cc4503ed9e56a7bcd9f2ca82b0c880a8",slug:"snake-venom-and-ecology",bookSignature:"Mohammad Manjur Shah, Umar Sharif, Tijjani Rufai Buhari and Tijjani Sabiu Imam",coverURL:"https://cdn.intechopen.com/books/images_new/10885.jpg",editedByType:"Edited by",publishedDate:"July 6th 2022",editors:[{id:"94128",title:"Dr.",name:"Mohammad Manjur",middleName:null,surname:"Shah",slug:"mohammad-manjur-shah",fullName:"Mohammad Manjur Shah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10381",title:"Electrocatalysis and Electrocatalysts for a Cleaner Environment",subtitle:"Fundamentals and Applications",isOpenForSubmission:!1,hash:"9dbafb0b297cf5cbdb220707e022a228",slug:"electrocatalysis-and-electrocatalysts-for-a-cleaner-environment-fundamentals-and-applications",bookSignature:"Lindiwe Eudora Khotseng",coverURL:"https://cdn.intechopen.com/books/images_new/10381.jpg",editedByType:"Edited by",publishedDate:"July 6th 2022",editors:[{id:"236596",title:"Dr.",name:"Lindiwe Eudora",middleName:null,surname:"Khotseng",slug:"lindiwe-eudora-khotseng",fullName:"Lindiwe Eudora Khotseng"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10900",title:"Prunus",subtitle:"Recent Advances",isOpenForSubmission:!1,hash:"9261926500acb26c4ae5a29eee78f0db",slug:"prunus-recent-advances",bookSignature:"Ayzin B. Küden and Ali Küden",coverURL:"https://cdn.intechopen.com/books/images_new/10900.jpg",editedByType:"Edited by",publishedDate:"July 6th 2022",editors:[{id:"200365",title:"Prof.",name:"Ayzin B.",middleName:"B.",surname:"Küden",slug:"ayzin-b.-kuden",fullName:"Ayzin B. Küden"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"183",title:"Hematology",slug:"hematology",parent:{id:"16",title:"Medicine",slug:"medicine"},numberOfBooks:40,numberOfSeries:0,numberOfAuthorsAndEditors:690,numberOfWosCitations:362,numberOfCrossrefCitations:262,numberOfDimensionsCitations:545,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"183",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"11321",title:"Anticoagulation",subtitle:"Current Perspectives",isOpenForSubmission:!1,hash:"141b615d62361de2af678b539f3061ed",slug:"anticoagulation-current-perspectives",bookSignature:"Xingshun Qi and Xiaozhong Guo",coverURL:"https://cdn.intechopen.com/books/images_new/11321.jpg",editedByType:"Edited by",editors:[{id:"197501",title:"Dr.",name:"Xingshun",middleName:null,surname:"Qi",slug:"xingshun-qi",fullName:"Xingshun Qi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10322",title:"Antiphospholipid Syndrome",subtitle:"Recent Advances in Clinical and Basic Aspects",isOpenForSubmission:!1,hash:"25759ed4dd8aa8c0e4b160b940d1b6f5",slug:"antiphospholipid-syndrome-recent-advances-in-clinical-and-basic-aspects",bookSignature:"Polona Žigon",coverURL:"https://cdn.intechopen.com/books/images_new/10322.jpg",editedByType:"Edited by",editors:[{id:"175000",title:"Dr.",name:"Polona",middleName:null,surname:"Žigon",slug:"polona-zigon",fullName:"Polona Žigon"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10876",title:"Blood",subtitle:"Updates on Hemodynamics and on Thalassemia",isOpenForSubmission:!1,hash:"ffca6b2c8514338c8e496d26f1483d89",slug:"blood-updates-on-hemodynamics-and-on-thalassemia",bookSignature:"Aise Seda Artis",coverURL:"https://cdn.intechopen.com/books/images_new/10876.jpg",editedByType:"Edited by",editors:[{id:"99453",title:"Dr.",name:"Aise Seda",middleName:null,surname:"Artis",slug:"aise-seda-artis",fullName:"Aise Seda Artis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10494",title:"Erythrocyte",subtitle:"A Peripheral Biomarker For Infection and Inflammation",isOpenForSubmission:!1,hash:"fa5f4b6ef59e28b6e7c1a739c57c5d2f",slug:"erythrocyte-a-peripheral-biomarker-for-infection-and-inflammation",bookSignature:"Kaneez Fatima Shad",coverURL:"https://cdn.intechopen.com/books/images_new/10494.jpg",editedByType:"Edited by",editors:[{id:"31988",title:"Prof.",name:"Kaneez",middleName:null,surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editedByType:"Edited by",editors:[{id:"35140",title:"Dr.",name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7845",title:"Platelets",subtitle:null,isOpenForSubmission:!1,hash:"d33b20516d6ff3a5b7446a882109ba26",slug:"platelets",bookSignature:"Steve W. Kerrigan",coverURL:"https://cdn.intechopen.com/books/images_new/7845.jpg",editedByType:"Edited by",editors:[{id:"73961",title:"Dr.",name:"Steve W.",middleName:null,surname:"Kerrigan",slug:"steve-w.-kerrigan",fullName:"Steve W. Kerrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8450",title:"Beta Thalassemia",subtitle:null,isOpenForSubmission:!1,hash:"976f72013cd8e78d8f65bfb1f51f0146",slug:"beta-thalassemia",bookSignature:"Marwa Zakaria and Tamer Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/8450.jpg",editedByType:"Edited by",editors:[{id:"187545",title:"Prof.",name:"Marwa",middleName:null,surname:"Zakaria",slug:"marwa-zakaria",fullName:"Marwa Zakaria"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8316",title:"Normal and Malignant B-Cell",subtitle:null,isOpenForSubmission:!1,hash:"a12608fa8d5fdb33c956f967974a4ef1",slug:"normal-and-malignant-b-cell",bookSignature:"Mourad Aribi",coverURL:"https://cdn.intechopen.com/books/images_new/8316.jpg",editedByType:"Edited by",editors:[{id:"40046",title:"Prof.",name:"Mourad",middleName:null,surname:"Aribi",slug:"mourad-aribi",fullName:"Mourad Aribi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7181",title:"Erythrocyte",subtitle:null,isOpenForSubmission:!1,hash:"267d215004c995048557176978208b15",slug:"erythrocyte",bookSignature:"Anil Tombak",coverURL:"https://cdn.intechopen.com/books/images_new/7181.jpg",editedByType:"Edited by",editors:[{id:"202814",title:"Associate Prof.",name:"Anil",middleName:null,surname:"Tombak",slug:"anil-tombak",fullName:"Anil Tombak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7874",title:"Germ Line Mutations Associated Leukemia",subtitle:null,isOpenForSubmission:!1,hash:"cb407bb000c66ebe6172b9dc3d6f9fb4",slug:"germ-line-mutations-associated-leukemia",bookSignature:"Zhan He Wu",coverURL:"https://cdn.intechopen.com/books/images_new/7874.jpg",editedByType:"Edited by",editors:[{id:"226446",title:"Dr.",name:"Zhan He",middleName:null,surname:"Wu",slug:"zhan-he-wu",fullName:"Zhan He Wu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6905",title:"Blood Groups",subtitle:null,isOpenForSubmission:!1,hash:"545ab2a5b402edec6332c7d632eba398",slug:"blood-groups",bookSignature:"Anil Tombak",coverURL:"https://cdn.intechopen.com/books/images_new/6905.jpg",editedByType:"Edited by",editors:[{id:"202814",title:"Associate Prof.",name:"Anil",middleName:null,surname:"Tombak",slug:"anil-tombak",fullName:"Anil Tombak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7125",title:"Iron Deficiency Anemia",subtitle:null,isOpenForSubmission:!1,hash:"25d82a6ea6c9d80b195bb40aad06be49",slug:"iron-deficiency-anemia",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/7125.jpg",editedByType:"Edited by",editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:40,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"39123",doi:"10.5772/50698",title:"Measurement Techniques for Red Blood Cell Deformability: Recent Advances",slug:"measurement-techniques-for-red-blood-cell-deformability-recent-advances",totalDownloads:7145,totalCrossrefCites:24,totalDimensionsCites:67,abstract:null,book:{id:"2607",slug:"blood-cell-an-overview-of-studies-in-hematology",title:"Blood Cell",fullTitle:"Blood Cell - An Overview of Studies in Hematology"},signatures:"Youngchan Kim, Kyoohyun Kim and YongKeun Park",authors:[{id:"143622",title:"Prof.",name:"YongKeun",middleName:null,surname:"Park",slug:"yongkeun-park",fullName:"YongKeun Park"},{id:"143623",title:"Mr.",name:"Kyoohyun",middleName:null,surname:"Kim",slug:"kyoohyun-kim",fullName:"Kyoohyun Kim"},{id:"143624",title:"Mr.",name:"Sangyeon",middleName:null,surname:"Cho",slug:"sangyeon-cho",fullName:"Sangyeon Cho"}]},{id:"31178",doi:"10.5772/38961",title:"Physiological Factors in the Interpretation of Equine Hematological Profile",slug:"haematological-profile-of-the-horse-phisiological-factors-influencing-equine-haematology",totalDownloads:10752,totalCrossrefCites:15,totalDimensionsCites:35,abstract:null,book:{id:"1830",slug:"hematology-science-and-practice",title:"Hematology",fullTitle:"Hematology - Science and Practice"},signatures:"K. Satué, A. Hernández and A. Muñoz",authors:[{id:"125292",title:"Dr.",name:"Katy",middleName:null,surname:"Satué Ambrojo",slug:"katy-satue-ambrojo",fullName:"Katy Satué Ambrojo"}]},{id:"55356",doi:"10.5772/intechopen.68617",title:"Neutrophils in Rheumatoid Arthritis: A Target for Discovering New Therapies Based on Natural Products",slug:"neutrophils-in-rheumatoid-arthritis-a-target-for-discovering-new-therapies-based-on-natural-products",totalDownloads:2059,totalCrossrefCites:9,totalDimensionsCites:12,abstract:"Rheumatoid arthritis (RA) is a systemic autoimmune disorder with an important inflammatory component in joints. Neutrophils are the most abundant leukocytes in inflamed joints, and play an essential role in the initiation and progression of RA. Neutrophil effector mechanisms include the release of proinflammatory cytokines, reactive oxygen and nitrogen species (ROS and RNS), and granules containing degradative enzymes, which can cause further damage to the tissue and amplify the neutrophil response. Therefore, the modulation of neutrophil migration and functions is a potential target for pharmacological intervention in arthritis. The pharmacologic treatment options for RA are diverse. The current treatments are mostly symptomatic and have side effects, high costs, and an increased risk of malignancies. Because of these limitations, there is a growing interest in the use of natural products as therapies or adjunct therapies. Herbal products have attracted considerable interest over the past decade because of their multiple beneficial effects such as their antioxidant, anti-inflammatory, antiproliferative, and immunomodulatory properties. This chapter focuses on the role of neutrophils in the pathogenesis of arthritis and the action of substances from natural products as putative antirheumatic therapies.",book:{id:"5834",slug:"role-of-neutrophils-in-disease-pathogenesis",title:"Role of Neutrophils in Disease Pathogenesis",fullTitle:"Role of Neutrophils in Disease Pathogenesis"},signatures:"Elaine Cruz Rosas, Luana Barbosa Correa and Maria das Graças\nHenriques",authors:[{id:"64332",title:"Dr.",name:"Maria Das Graças",middleName:null,surname:"Henriques",slug:"maria-das-gracas-henriques",fullName:"Maria Das Graças Henriques"},{id:"197932",title:"Dr.",name:"Elaine",middleName:"Cruz",surname:"Rosas",slug:"elaine-rosas",fullName:"Elaine Rosas"},{id:"199677",title:"MSc.",name:"Luana",middleName:null,surname:"Correa",slug:"luana-correa",fullName:"Luana Correa"}]},{id:"46041",doi:"10.5772/57335",title:"An Insight into the Abnormal Fibrin Clots — Its Pathophysiological Roles",slug:"an-insight-into-the-abnormal-fibrin-clots-its-pathophysiological-roles",totalDownloads:3896,totalCrossrefCites:4,totalDimensionsCites:11,abstract:null,book:{id:"3836",slug:"fibrinolysis-and-thrombolysis",title:"Fibrinolysis and Thrombolysis",fullTitle:"Fibrinolysis and Thrombolysis"},signatures:"Payel Bhattacharjee and Debasish Bhattacharyya",authors:[{id:"88185",title:"Prof.",name:"Debasish",middleName:null,surname:"Bhattacharyya",slug:"debasish-bhattacharyya",fullName:"Debasish Bhattacharyya"},{id:"170045",title:"Ms.",name:"Payel",middleName:null,surname:"Bhattacharjee",slug:"payel-bhattacharjee",fullName:"Payel Bhattacharjee"}]},{id:"39110",doi:"10.5772/48250",title:"Laboratory Reference Intervals in Africa",slug:"laboratory-reference-intervals-in-africa",totalDownloads:4494,totalCrossrefCites:0,totalDimensionsCites:10,abstract:null,book:{id:"2607",slug:"blood-cell-an-overview-of-studies-in-hematology",title:"Blood Cell",fullTitle:"Blood Cell - An Overview of Studies in Hematology"},signatures:"Clement E. Zeh, Collins O. Odhiambo and Lisa A. Mills",authors:[{id:"141066",title:"Dr",name:"Clement",middleName:null,surname:"Zeh",slug:"clement-zeh",fullName:"Clement Zeh"}]}],mostDownloadedChaptersLast30Days:[{id:"66797",title:"Blood Transfusion Reactions",slug:"blood-transfusion-reactions",totalDownloads:2617,totalCrossrefCites:0,totalDimensionsCites:0,abstract:"Blood transfusion reaction/adverse transfusion reactions could be fatal/severe or mild, immediate or delayed, immunological or nonimmunological, and infectious or noninfectious, and attention is paid particularly to the incidence, possible causes and pathophysiology, clinical features, and management of each type with the aim of improving awareness and raising consciousness towards improving blood safety and judicious use of blood so as to forestall these blood transfusion reactions as much as possible. This chapter serves as a synopsis to adverse blood reactions, which are very common but apparently more often under-recognized and/or under-reported particularly in developing countries. This should sharpen the consciousness of all health practitioners involved in blood transfusion services towards taking measures at preventing transfusion reactions right from donor selection up to the infusion of blood into the recipients.",book:{id:"6905",slug:"blood-groups",title:"Blood Groups",fullTitle:"Blood Groups"},signatures:"John Ayodele Olaniyi",authors:[{id:"202764",title:"Dr.",name:"John",middleName:null,surname:"Olaniyi",slug:"john-olaniyi",fullName:"John Olaniyi"}]},{id:"49387",title:"Thalassemia — From Genotype to Phenotype",slug:"thalassemia-from-genotype-to-phenotype",totalDownloads:4877,totalCrossrefCites:2,totalDimensionsCites:3,abstract:"Thalassemia encompasses serious diseases with complex pathophysiology that is difficult to explain since it is considered a group of defects with similar clinical effects, still not a single disorder.",book:{id:"4729",slug:"inherited-hemoglobin-disorders",title:"Inherited Hemoglobin Disorders",fullTitle:"Inherited Hemoglobin Disorders"},signatures:"Ghada Y. El-Kamah and Khalda S. Amr",authors:[{id:"58735",title:"Prof.",name:"Ghada",middleName:null,surname:"El-Kamah",slug:"ghada-el-kamah",fullName:"Ghada El-Kamah"},{id:"176872",title:"Prof.",name:"Khalda",middleName:null,surname:"Amr",slug:"khalda-amr",fullName:"Khalda Amr"}]},{id:"51831",title:"Disorders Mimicking Myelodysplastic Syndrome and Difficulties in its Diagnosis",slug:"disorders-mimicking-myelodysplastic-syndrome-and-difficulties-in-its-diagnosis",totalDownloads:4511,totalCrossrefCites:1,totalDimensionsCites:6,abstract:"Myelodysplastic morphology of blood cells can be encountered not only in myelodysplastic syndrome (MDS) but also in nonclonal disorders like viral, bacterial, parasitic infections, juvenile rheumatoid arthritis, polyarteritis nodosa, immune thrombocytopenic purpura (ITP), iron deficiency anemia, megaloblastic anemia, dysgranulopoietic neutropenia, congenital neutropenia, cases with microdeletion 22q11.2, malignant lymphoma, after administration of granulocyte colony stimulating factor, chemotherapy, steroids, smoking, alcohol, posttransplantation, copper deficiency also, together with or without cytopenia. Absence of cytogenetic abnormality in 50–70% of cases with MDS, some overlapping morphological and/or pathophysiological features make it challenging to differentiate between MDS and other diseases/disorders like aplastic anemia, refractory ITP, copper deficiency. Transient genetic abnormalities including monosomy 7 in megaloblastic anemia; increased immature myeloid cells in bone marrow of cases with copper, vitamin B12, or folic acid deficiency in the setting of cytopenia and dysmorphism may also lead to the misdiagnosis of MDS. On the other hand, there are also cases of transient MDS. In this chapter, a literature is be presented to draw attention of the readers on the disorders that mimic MDS. Additionally, our personal experiences are also be shared. Awareness of disorders mimicking MDS may prevent over- or underdiagnosis of MDS.",book:{id:"5276",slug:"myelodysplastic-syndromes",title:"Myelodysplastic Syndromes",fullTitle:"Myelodysplastic Syndromes"},signatures:"Lale Olcay and Sevgi Yetgin",authors:[{id:"184156",title:"Prof.",name:"Lale",middleName:null,surname:"Olcay",slug:"lale-olcay",fullName:"Lale Olcay"}]},{id:"64871",title:"Diagnosis and Classification of Myelodysplastic Syndrome",slug:"diagnosis-and-classification-of-myelodysplastic-syndrome",totalDownloads:3212,totalCrossrefCites:0,totalDimensionsCites:1,abstract:"Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disorder characterized by morphological dysplastic changes in one or more of the major hematopoietic cell lines. MDS can present with varying degrees of single or multiple cytopenias including neutropenia, anemia and thrombocytopenia. Presentation of MDS can range from asymptomatic to life threatening. MDS diagnosis and classification present important challenges, particularly in the distinction from benign conditions. French-American-British (FAB) classification proposed a classification based on easily obtainable laboratory information and was recommended in early and as modified by guidelines of new classification of World Health Organization (WHO). The strategy of diagnostic laboratory in MDS depends on morphological changes and is based on existence of dysplastic changes in the peripheral blood and bone marrow including peripheral blood smear, bone marrow aspirate smear and bone marrow trephine biopsy. The correct morphological interpretation and the use of cytogenetics, immunophenotyping, immunohistochemistry and molecular analysis will give valuable information on diagnosis and prognosis.",book:{id:"7138",slug:"recent-developments-in-myelodysplastic-syndromes",title:"Recent Developments in Myelodysplastic Syndromes",fullTitle:"Recent Developments in Myelodysplastic Syndromes"},signatures:"Gamal Abdul Hamid, Abdul Wahab Al-Nehmi and Safa Shukry",authors:[{id:"36487",title:"Prof.",name:"Gamal",middleName:null,surname:"Abdul Hamid",slug:"gamal-abdul-hamid",fullName:"Gamal Abdul Hamid"},{id:"273724",title:"Dr.",name:"Safa",middleName:null,surname:"Shukry",slug:"safa-shukry",fullName:"Safa Shukry"},{id:"277511",title:"Dr.",name:"Abdulwahab",middleName:null,surname:"Al-Nehmi",slug:"abdulwahab-al-nehmi",fullName:"Abdulwahab Al-Nehmi"}]},{id:"70780",title:"Laboratory Diagnosis of β-Thalassemia and HbE",slug:"laboratory-diagnosis-of-thalassemia-and-hbe",totalDownloads:1400,totalCrossrefCites:1,totalDimensionsCites:2,abstract:"β-Thalassemia and HbE, each, is a syndrome resulted from quantitative and qualitative defects of β-globin chain, respectively. In addition to history retrieve and physical examination, diagnosis of these disorders requires laboratory information. Laboratory tests that are conventionally performed to diagnose the β-thalassemia and HbE are classified into two groups, based on the purposes, including the screening tests and confirmatory tests. The screening tests are aimed to screen for carriers of the β-thalassemia and HbE, while confirmatory tests are the tests performed to definitely diagnose these disorders. This chapter will explain all of these tests, the information of which will be useful for those who are working and interested in the β-thalassemia and HbE.",book:{id:"8450",slug:"beta-thalassemia",title:"Beta Thalassemia",fullTitle:"Beta Thalassemia"},signatures:"Thanusak Tatu",authors:null}],onlineFirstChaptersFilter:{topicId:"183",limit:6,offset:0},onlineFirstChaptersCollection:[{id:"82161",title:"Blood Groups More than Inheritance of Antigenic Substances: Susceptibility to Some Diseases",slug:"blood-groups-more-than-inheritance-of-antigenic-substances-susceptibility-to-some-diseases",totalDownloads:9,totalDimensionsCites:0,doi:"10.5772/intechopen.104593",abstract:"Blood group antigens represent polymorphic traits inherited among individuals and populations. The objective of this chapter is to review articles that have reported; the association between blood group antigens and susceptibility to some diseases. Findings showed that O blood group had a greater frequency of severe infections such as E coli, cholera and blood group A was associated with incidence of smallpox and some bacterial infections. These are principally based on presence or absence of “H-like” and “A and B-like” antigens markers. Antigens A, B and H are connected to N-glycans of vWF and reduces the half-life of the protein (10 hours) for group O while non-O groups, 25 hours. The loss of A, B, and H antigens as malignancy progresses was linked to potential metastasis. Similarly, some tumors have A or A-like antigens this explains the propensity of group A to develop tumors. Blood type incompatibility between mother and foetus sensitizes the mother to develop alloantibodies that could potentially cause death of the foetus in utero, a condition known hydrops. Reviewed articles have reported close link between blood group antigens and susceptibility diseases. More studies are required to rationalize the mechanism associated to this.",book:{id:"10728",title:"Blood Groups - More Than Inheritance of Antigenic Substances",coverURL:"https://cdn.intechopen.com/books/images_new/10728.jpg"},signatures:"Williams Bitty Azachi and Kuschak Mathias Dakop"},{id:"80344",title:"RH Groups",slug:"rh-groups",totalDownloads:25,totalDimensionsCites:0,doi:"10.5772/intechopen.102421",abstract:"In 1939, a mother gave birth to a stillborn baby and underwent blood transfusion with ABO-matched blood from her husband. This resulted in a hemolytic transfusion reaction (HTR). Levine and Stetson postulated that a novel antigen was present in the baby and father, which was absent in the mother. Therefore, the mother’s immune system recognized this antigen and produced antibodies against it. This condition has been known as the hemolytic disease of the newborn for a long period of time. Since the antenatal management of the fetus has been developed, the term has been modified to hemolytic disease of the fetus and newborn (HDFN). This case led to the discovery of the antibody against the first antigen of the RH blood group system, the D antigen. To date, 56 antigens have been recognized within the RH blood group system. The five main antigens are D, C, c, E, and e. As observed in the above-mentioned case, the antibodies against these antigens are implicated in HTR and HDFN.",book:{id:"10728",title:"Blood Groups - More Than Inheritance of Antigenic Substances",coverURL:"https://cdn.intechopen.com/books/images_new/10728.jpg"},signatures:"Amr J. Halawani"},{id:"80254",title:"Neutrophil-Specific Antigens: Immunobiology, Genetics and Roles in Clinical Disorders",slug:"neutrophil-specific-antigens-immunobiology-genetics-and-roles-in-clinical-disorders",totalDownloads:36,totalDimensionsCites:0,doi:"10.5772/intechopen.102431",abstract:"Neutrophils are the most abundant nucleated cells in blood circulation and play important roles in the innate and adaptive immune responses. Neutrophil-specific antigens, only expressed on neutrophils, are glycoproteins originally identified in studies on neonatal neutropenia due to fetal-maternal incompatibility and autoimmune neutropenia of infancy. The most investigated neutrophil–specific antigens are the NA and NB antigens that their incompatibilities also cause transfusion-induced febrile reactions and acute lung injury, a potentially fatal reaction, and in bone marrow transplantation, causing graft rejection. NA antigens are members of the immunoglobulin superfamily and are low-affinity Fc-receptors FcγRIIIb (CD16b). Fc receptors connect the F(ab), the antigen-binding fragment of the antibody molecules, to neutrophils and lead them to recognize and phagocytize the targeted antigens. The NB (CD177) antigen belongs to the urokinase-type Plasminogen Activator Receptor Superfamily (uPAR, CD59, Ly6), but its specific functions have not been fully determined. It is known, however, that NB antigen binds proteinase-3 (PR3 to the neutrophil membrane), a serine protease. In clinical studies, it was also demonstrated that NB expression is highly elevated in Polycythemia Vera and is unexpectedly expressed in some cancer tissues. Neutrophil-specific antigens are examples of antigens that have important biological and clinical activities beyond antigenicity.",book:{id:"10728",title:"Blood Groups - More Than Inheritance of Antigenic Substances",coverURL:"https://cdn.intechopen.com/books/images_new/10728.jpg"},signatures:"Parviz Lalezari and Behnaz Bayat"},{id:"80716",title:"The ABO Blood Group System and Plasmodium falciparum (Pf ) Infection in Three Ethnic Groups Living in the Stable and Seasonal Malaria Transmission Areas of Burkina Faso (BF)",slug:"the-abo-blood-group-system-and-plasmodium-falciparum-pf-infection-in-three-ethnic-groups-living-in-t",totalDownloads:92,totalDimensionsCites:0,doi:"10.5772/intechopen.102475",abstract:"Genetic factors, including red blood cell polymorphisms, influence the severity of disease due to infection with Plasmodium falciparum (Pf). Studies show that these genetic factors associated with malaria susceptibility or resistance vary geographically, ethnically, and racially. We performed cross-sectional surveys in population living in rural villages from three ethnic groups. The blood group (BG) was determined genetically using two polymorphisms (rs8176719 and rs8176746). Out of 548 participants, 29.7% were Mossi, 38.2% were Fulani, and 32.1% were Rimaibe. The distribution of BG was, respectively, A: 25.5%, B: 26.6%, AB: 7.3%, and O: 40.5%. BG O was not only the common blood type overall, but was higher in Fulani (52.6%) than others. Fulani was associated with a reduced risk of infection and lower parasite densities than sympatric populations. The subjects with non-O blood were less susceptible to malaria infection. An association between ethnicity and malaria infection during the high transmission season as well as an association between the non-O blood group and malaria infections according to ethnicity was found. This was also true when ethnic groups were considered separately. Our results have demonstrated that the Fulani are not only less susceptible to Pf malaria infection, but when infected have lower parasite densities. Individuals with non-O blood are at lower risk of infection.",book:{id:"10728",title:"Blood Groups - More Than Inheritance of Antigenic Substances",coverURL:"https://cdn.intechopen.com/books/images_new/10728.jpg"},signatures:"Edith Christiane Bougouma, Alphonse Ouedraogo and Sodiomon Bienvenu Sirima"},{id:"80474",title:"ABO Blood Group and Thromboembolic Diseases",slug:"abo-blood-group-and-thromboembolic-diseases",totalDownloads:42,totalDimensionsCites:0,doi:"10.5772/intechopen.102757",abstract:"Thromboembolic diseases are usually inherited in the family. The tendency to repeat in an individual is a phenomenon that allows it to be studied. The inheritance and recurrence of thromboembolic diseases, of course, have individual risk factors for this occurrence. In the past, the ABO blood group was only needed for transfusion and organ transplant therapy. Over time, scientists think that blood type is a risk factor for certain diseases, including thromboembolism. Many studies divide between type O and non-O blood groups, both of which are distinguished by the presence of antigens on the cell surface and antibodies in the plasma of individuals. Type O does not have A, B antigens but has antibodies against A, B antigens, and vice versa for the non-O type. Many studies have shown that the non-O blood group has a risk factor for thromboembolic diseases, commonly due to higher levels of von Willebrand factor (VWF) and factor VIII (FVIII). These thromboembolic events can occur in arteries or venous. Thromboembolic manifestations are often associated with cardiovascular diseases for arterial thrombosis; and deep vein thrombosis (DVT) and pulmonary embolism (PE) for venous thromboembolism (VTE).",book:{id:"10728",title:"Blood Groups - More Than Inheritance of Antigenic Substances",coverURL:"https://cdn.intechopen.com/books/images_new/10728.jpg"},signatures:"Yetti Hernaningsih"},{id:"78997",title:"ABO Blood Groups and Risk of Glioma",slug:"abo-blood-groups-and-risk-of-glioma",totalDownloads:60,totalDimensionsCites:0,doi:"10.5772/intechopen.100566",abstract:"Gliomas are one of the most common primary brain tumors and the etiology of gliomas remains unknown in most cases. The aim of this case–control study was to investigate possible association between incidence in relation to glioma and certain blood groups. This study included 100 histopathologically verified cases of glioma and 200 age and sex-matched controls without malignant diseases that were admitted to the same hospital. The results revealed that the patients with group AB were at 3.5-fold increased risk of developing glioma compared to the patients with other ABO blood groups. In this particular study, there was more male patients with glioma with the blood group AB. However, mechanisms that explain the relationship between the blood groups ABO and a cancer risk are unclear. Several hypotheses have been proposed, including the one with a modulatory role of blood group ABO antigens. In addition, the blood group ABO system regulates the level of circulating proinflammatory and adhesion molecules which play a significant role in the tumorigenesis process. Additionally, the recent discovery that includes the von Willebrand factor (vWF) as an important modulator of angiogenesis and apoptosis provides one plausible explanation as regards the role of the blood group ABO in the tumorigenesis process. To our knowledge, this is the first study that examined the relationship of blood group in patients diagnosed with glioma among the Serbian population. Moreover, for the first time our study results suggested that blood group AB increased the risk of glioma. The results of this study suggested that the blood group AB could be one of hereditary factors which had an influence on the occurrence of glioma. The further research is needed on a larger sample, to confirm these findings and the possible mechanisms by which the ABO system contributes to the pathology of glioma.",book:{id:"10728",title:"Blood Groups - More Than Inheritance of Antigenic Substances",coverURL:"https://cdn.intechopen.com/books/images_new/10728.jpg"},signatures:"Ana Azanjac Arsic"}],onlineFirstChaptersTotal:7},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:0,limit:8,total:null},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:90,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:104,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:32,numberOfPublishedChapters:320,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:12,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:141,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:133,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:107,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:5,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:17,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}},{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}}]},series:{item:{id:"14",title:"Artificial Intelligence",doi:"10.5772/intechopen.79920",issn:"2633-1403",scope:"Artificial Intelligence (AI) is a rapidly developing multidisciplinary research area that aims to solve increasingly complex problems. In today's highly integrated world, AI promises to become a robust and powerful means for obtaining solutions to previously unsolvable problems. This Series is intended for researchers and students alike interested in this fascinating field and its many applications.",coverUrl:"https://cdn.intechopen.com/series/covers/14.jpg",latestPublicationDate:"July 5th, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:9,editor:{id:"218714",title:"Prof.",name:"Andries",middleName:null,surname:"Engelbrecht",slug:"andries-engelbrecht",fullName:"Andries Engelbrecht",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRNR8QAO/Profile_Picture_1622640468300",biography:"Andries Engelbrecht received the Masters and PhD degrees in Computer Science from the University of Stellenbosch, South Africa, in 1994 and 1999 respectively. He is currently appointed as the Voigt Chair in Data Science in the Department of Industrial Engineering, with a joint appointment as Professor in the Computer Science Division, Stellenbosch University. Prior to his appointment at Stellenbosch University, he has been at the University of Pretoria, Department of Computer Science (1998-2018), where he was appointed as South Africa Research Chair in Artifical Intelligence (2007-2018), the head of the Department of Computer Science (2008-2017), and Director of the Institute for Big Data and Data Science (2017-2018). In addition to a number of research articles, he has written two books, Computational Intelligence: An Introduction and Fundamentals of Computational Swarm Intelligence.",institutionString:null,institution:{name:"Stellenbosch University",institutionURL:null,country:{name:"South Africa"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:6,paginationItems:[{id:"22",title:"Applied Intelligence",coverUrl:"https://cdn.intechopen.com/series_topics/covers/22.jpg",isOpenForSubmission:!0,editor:{id:"27170",title:"Prof.",name:"Carlos",middleName:"M.",surname:"Travieso-Gonzalez",slug:"carlos-travieso-gonzalez",fullName:"Carlos Travieso-Gonzalez",profilePictureURL:"https://mts.intechopen.com/storage/users/27170/images/system/27170.jpeg",biography:"Carlos M. Travieso-González received his MSc degree in Telecommunication Engineering at Polytechnic University of Catalonia (UPC), Spain in 1997, and his Ph.D. degree in 2002 at the University of Las Palmas de Gran Canaria (ULPGC-Spain). He is a full professor of signal processing and pattern recognition and is head of the Signals and Communications Department at ULPGC, teaching from 2001 on subjects on signal processing and learning theory. His research lines are biometrics, biomedical signals and images, data mining, classification system, signal and image processing, machine learning, and environmental intelligence. He has researched in 52 international and Spanish research projects, some of them as head researcher. He is co-author of 4 books, co-editor of 27 proceedings books, guest editor for 8 JCR-ISI international journals, and up to 24 book chapters. He has over 450 papers published in international journals and conferences (81 of them indexed on JCR – ISI - Web of Science). He has published seven patents in the Spanish Patent and Trademark Office. He has been a supervisor on 8 Ph.D. theses (11 more are under supervision), and 130 master theses. He is the founder of The IEEE IWOBI conference series and the president of its Steering Committee, as well as the founder of both the InnoEducaTIC and APPIS conference series. He is an evaluator of project proposals for the European Union (H2020), Medical Research Council (MRC, UK), Spanish Government (ANECA, Spain), Research National Agency (ANR, France), DAAD (Germany), Argentinian Government, and the Colombian Institutions. He has been a reviewer in different indexed international journals (<70) and conferences (<250) since 2001. He has been a member of the IASTED Technical Committee on Image Processing from 2007 and a member of the IASTED Technical Committee on Artificial Intelligence and Expert Systems from 2011. \n\nHe has held the general chair position for the following: ACM-APPIS (2020, 2021), IEEE-IWOBI (2019, 2020 and 2020), A PPIS (2018, 2019), IEEE-IWOBI (2014, 2015, 2017, 2018), InnoEducaTIC (2014, 2017), IEEE-INES (2013), NoLISP (2011), JRBP (2012), and IEEE-ICCST (2005)\n\nHe is an associate editor of the Computational Intelligence and Neuroscience Journal (Hindawi – Q2 JCR-ISI). He was vice dean from 2004 to 2010 in the Higher Technical School of Telecommunication Engineers at ULPGC and the vice dean of Graduate and Postgraduate Studies from March 2013 to November 2017. He won the “Catedra Telefonica” Awards in Modality of Knowledge Transfer, 2017, 2018, and 2019 editions, and awards in Modality of COVID Research in 2020.\n\nPublic References:\nResearcher ID http://www.researcherid.com/rid/N-5967-2014\nORCID https://orcid.org/0000-0002-4621-2768 \nScopus Author ID https://www.scopus.com/authid/detail.uri?authorId=6602376272\nScholar Google https://scholar.google.es/citations?user=G1ks9nIAAAAJ&hl=en \nResearchGate https://www.researchgate.net/profile/Carlos_Travieso",institutionString:null,institution:{name:"University of Las Palmas de Gran Canaria",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null},{id:"23",title:"Computational Neuroscience",coverUrl:"https://cdn.intechopen.com/series_topics/covers/23.jpg",isOpenForSubmission:!0,editor:{id:"14004",title:"Dr.",name:"Magnus",middleName:null,surname:"Johnsson",slug:"magnus-johnsson",fullName:"Magnus Johnsson",profilePictureURL:"https://mts.intechopen.com/storage/users/14004/images/system/14004.png",biography:"Dr Magnus Johnsson is a cross-disciplinary scientist, lecturer, scientific editor and AI/machine learning consultant from Sweden. \n\nHe is currently at Malmö University in Sweden, but also held positions at Lund University in Sweden and at Moscow Engineering Physics Institute. \nHe holds editorial positions at several international scientific journals and has served as a scientific editor for books and special journal issues. \nHis research interests are wide and include, but are not limited to, autonomous systems, computer modeling, artificial neural networks, artificial intelligence, cognitive neuroscience, cognitive robotics, cognitive architectures, cognitive aids and the philosophy of mind. \n\nDr. Johnsson has experience from working in the industry and he has a keen interest in the application of neural networks and artificial intelligence to fields like industry, finance, and medicine. \n\nWeb page: www.magnusjohnsson.se",institutionString:null,institution:{name:"Malmö University",institutionURL:null,country:{name:"Sweden"}}},editorTwo:null,editorThree:null},{id:"24",title:"Computer Vision",coverUrl:"https://cdn.intechopen.com/series_topics/covers/24.jpg",isOpenForSubmission:!0,editor:{id:"294154",title:"Prof.",name:"George",middleName:null,surname:"Papakostas",slug:"george-papakostas",fullName:"George Papakostas",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002hYaGbQAK/Profile_Picture_1624519712088",biography:"George A. Papakostas has received a diploma in Electrical and Computer Engineering in 1999 and the M.Sc. and Ph.D. degrees in Electrical and Computer Engineering in 2002 and 2007, respectively, from the Democritus University of Thrace (DUTH), Greece. Dr. Papakostas serves as a Tenured Full Professor at the Department of Computer Science, International Hellenic University, Greece. Dr. Papakostas has 10 years of experience in large-scale systems design as a senior software engineer and technical manager, and 20 years of research experience in the field of Artificial Intelligence. Currently, he is the Head of the “Visual Computing” division of HUman-MAchines INteraction Laboratory (HUMAIN-Lab) and the Director of the MPhil program “Advanced Technologies in Informatics and Computers” hosted by the Department of Computer Science, International Hellenic University. He has (co)authored more than 150 publications in indexed journals, international conferences and book chapters, 1 book (in Greek), 3 edited books, and 5 journal special issues. His publications have more than 2100 citations with h-index 27 (GoogleScholar). His research interests include computer/machine vision, machine learning, pattern recognition, computational intelligence. \nDr. Papakostas served as a reviewer in numerous journals, as a program\ncommittee member in international conferences and he is a member of the IAENG, MIR Labs, EUCogIII, INSTICC and the Technical Chamber of Greece (TEE).",institutionString:null,institution:{name:"International Hellenic University",institutionURL:null,country:{name:"Greece"}}},editorTwo:null,editorThree:null},{id:"25",title:"Evolutionary Computation",coverUrl:"https://cdn.intechopen.com/series_topics/covers/25.jpg",isOpenForSubmission:!0,editor:{id:"136112",title:"Dr.",name:"Sebastian",middleName:null,surname:"Ventura Soto",slug:"sebastian-ventura-soto",fullName:"Sebastian Ventura Soto",profilePictureURL:"https://mts.intechopen.com/storage/users/136112/images/system/136112.png",biography:"Sebastian Ventura is a Spanish researcher, a full professor with the Department of Computer Science and Numerical Analysis, University of Córdoba. Dr Ventura also holds the positions of Affiliated Professor at Virginia Commonwealth University (Richmond, USA) and Distinguished Adjunct Professor at King Abdulaziz University (Jeddah, Saudi Arabia). Additionally, he is deputy director of the Andalusian Research Institute in Data Science and Computational Intelligence (DaSCI) and heads the Knowledge Discovery and Intelligent Systems Research Laboratory. He has published more than ten books and over 300 articles in journals and scientific conferences. Currently, his work has received over 18,000 citations according to Google Scholar, including more than 2200 citations in 2020. In the last five years, he has published more than 60 papers in international journals indexed in the JCR (around 70% of them belonging to first quartile journals) and he has edited some Springer books “Supervised Descriptive Pattern Mining” (2018), “Multiple Instance Learning - Foundations and Algorithms” (2016), and “Pattern Mining with Evolutionary Algorithms” (2016). He has also been involved in more than 20 research projects supported by the Spanish and Andalusian governments and the European Union. He currently belongs to the editorial board of PeerJ Computer Science, Information Fusion and Engineering Applications of Artificial Intelligence journals, being also associate editor of Applied Computational Intelligence and Soft Computing and IEEE Transactions on Cybernetics. Finally, he is editor-in-chief of Progress in Artificial Intelligence. He is a Senior Member of the IEEE Computer, the IEEE Computational Intelligence, and the IEEE Systems, Man, and Cybernetics Societies, and the Association of Computing Machinery (ACM). Finally, his main research interests include data science, computational intelligence, and their applications.",institutionString:null,institution:{name:"University of Córdoba",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null},{id:"26",title:"Machine Learning and Data Mining",coverUrl:"https://cdn.intechopen.com/series_topics/covers/26.jpg",isOpenForSubmission:!0,editor:{id:"24555",title:"Dr.",name:"Marco Antonio",middleName:null,surname:"Aceves Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves Fernandez",profilePictureURL:"https://mts.intechopen.com/storage/users/24555/images/system/24555.jpg",biography:"Dr. Marco Antonio Aceves Fernandez obtained his B.Sc. (Eng.) in Telematics from the Universidad de Colima, Mexico. He obtained both his M.Sc. and Ph.D. from the University of Liverpool, England, in the field of Intelligent Systems. He is a full professor at the Universidad Autonoma de Queretaro, Mexico, and a member of the National System of Researchers (SNI) since 2009. Dr. Aceves Fernandez has published more than 80 research papers as well as a number of book chapters and congress papers. He has contributed in more than 20 funded research projects, both academic and industrial, in the area of artificial intelligence, ranging from environmental, biomedical, automotive, aviation, consumer, and robotics to other applications. He is also a honorary president at the National Association of Embedded Systems (AMESE), a senior member of the IEEE, and a board member of many institutions. His research interests include intelligent and embedded systems.",institutionString:"Universidad Autonoma de Queretaro",institution:{name:"Autonomous University of Queretaro",institutionURL:null,country:{name:"Mexico"}}},editorTwo:null,editorThree:null},{id:"27",title:"Multi-Agent Systems",coverUrl:"https://cdn.intechopen.com/series_topics/covers/27.jpg",isOpenForSubmission:!0,editor:{id:"148497",title:"Dr.",name:"Mehmet",middleName:"Emin",surname:"Aydin",slug:"mehmet-aydin",fullName:"Mehmet Aydin",profilePictureURL:"https://mts.intechopen.com/storage/users/148497/images/system/148497.jpg",biography:"Dr. Mehmet Emin Aydin is a Senior Lecturer with the Department of Computer Science and Creative Technology, the University of the West of England, Bristol, UK. His research interests include swarm intelligence, parallel and distributed metaheuristics, machine learning, intelligent agents and multi-agent systems, resource planning, scheduling and optimization, combinatorial optimization. Dr. Aydin is currently a Fellow of Higher Education Academy, UK, a member of EPSRC College, a senior member of IEEE and a senior member of ACM. In addition to being a member of advisory committees of many international conferences, he is an Editorial Board Member of various peer-reviewed international journals. He has served as guest editor for a number of special issues of peer-reviewed international journals.",institutionString:null,institution:{name:"University of the West of England",institutionURL:null,country:{name:"United Kingdom"}}},editorTwo:null,editorThree:null}]},overviewPageOFChapters:{paginationCount:20,paginationItems:[{id:"82526",title:"Deep Multiagent Reinforcement Learning Methods Addressing the Scalability Challenge",doi:"10.5772/intechopen.105627",signatures:"Theocharis Kravaris and George A. Vouros",slug:"deep-multiagent-reinforcement-learning-methods-addressing-the-scalability-challenge",totalDownloads:1,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Multi-Agent Technologies and Machine Learning",coverURL:"https://cdn.intechopen.com/books/images_new/11445.jpg",subseries:{id:"27",title:"Multi-Agent Systems"}}},{id:"82196",title:"Multi-Features Assisted Age Invariant Face Recognition and Retrieval Using CNN with Scale Invariant Heat Kernel Signature",doi:"10.5772/intechopen.104944",signatures:"Kamarajugadda Kishore Kumar and Movva Pavani",slug:"multi-features-assisted-age-invariant-face-recognition-and-retrieval-using-cnn-with-scale-invariant-",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Pattern Recognition - New Insights",coverURL:"https://cdn.intechopen.com/books/images_new/11442.jpg",subseries:{id:"26",title:"Machine Learning and Data Mining"}}},{id:"82063",title:"Evaluating Similarities and Differences between Machine Learning and Traditional Statistical Modeling in Healthcare Analytics",doi:"10.5772/intechopen.105116",signatures:"Michele Bennett, Ewa J. Kleczyk, Karin Hayes and Rajesh Mehta",slug:"evaluating-similarities-and-differences-between-machine-learning-and-traditional-statistical-modelin",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Machine Learning and Data Mining - Annual Volume 2022",coverURL:"https://cdn.intechopen.com/books/images_new/11422.jpg",subseries:{id:"26",title:"Machine Learning and Data Mining"}}},{id:"81791",title:"Self-Supervised Contrastive Representation Learning in Computer Vision",doi:"10.5772/intechopen.104785",signatures:"Yalin Bastanlar and Semih Orhan",slug:"self-supervised-contrastive-representation-learning-in-computer-vision",totalDownloads:30,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Pattern Recognition - New Insights",coverURL:"https://cdn.intechopen.com/books/images_new/11442.jpg",subseries:{id:"26",title:"Machine Learning and Data Mining"}}}]},overviewPagePublishedBooks:{paginationCount:9,paginationItems:[{type:"book",id:"7723",title:"Artificial Intelligence",subtitle:"Applications in Medicine and Biology",coverURL:"https://cdn.intechopen.com/books/images_new/7723.jpg",slug:"artificial-intelligence-applications-in-medicine-and-biology",publishedDate:"July 31st 2019",editedByType:"Edited by",bookSignature:"Marco Antonio Aceves-Fernandez",hash:"a3852659e727f95c98c740ed98146011",volumeInSeries:1,fullTitle:"Artificial Intelligence - Applications in Medicine and Biology",editors:[{id:"24555",title:"Dr.",name:"Marco Antonio",middleName:null,surname:"Aceves Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves Fernandez",profilePictureURL:"https://mts.intechopen.com/storage/users/24555/images/system/24555.jpg",biography:"Dr. Marco Antonio Aceves Fernandez obtained his B.Sc. (Eng.) in Telematics from the Universidad de Colima, Mexico. He obtained both his M.Sc. and Ph.D. from the University of Liverpool, England, in the field of Intelligent Systems. He is a full professor at the Universidad Autonoma de Queretaro, Mexico, and a member of the National System of Researchers (SNI) since 2009. Dr. Aceves Fernandez has published more than 80 research papers as well as a number of book chapters and congress papers. He has contributed in more than 20 funded research projects, both academic and industrial, in the area of artificial intelligence, ranging from environmental, biomedical, automotive, aviation, consumer, and robotics to other applications. He is also a honorary president at the National Association of Embedded Systems (AMESE), a senior member of the IEEE, and a board member of many institutions. His research interests include intelligent and embedded systems.",institutionString:"Universidad Autonoma de Queretaro",institution:{name:"Autonomous University of Queretaro",institutionURL:null,country:{name:"Mexico"}}}]},{type:"book",id:"7726",title:"Swarm Intelligence",subtitle:"Recent Advances, New Perspectives and Applications",coverURL:"https://cdn.intechopen.com/books/images_new/7726.jpg",slug:"swarm-intelligence-recent-advances-new-perspectives-and-applications",publishedDate:"December 4th 2019",editedByType:"Edited by",bookSignature:"Javier Del Ser, Esther Villar and Eneko Osaba",hash:"e7ea7e74ce7a7a8e5359629e07c68d31",volumeInSeries:2,fullTitle:"Swarm Intelligence - Recent Advances, New Perspectives and Applications",editors:[{id:"49813",title:"Dr.",name:"Javier",middleName:null,surname:"Del Ser",slug:"javier-del-ser",fullName:"Javier Del Ser",profilePictureURL:"https://mts.intechopen.com/storage/users/49813/images/system/49813.png",biography:"Prof. Dr. Javier Del Ser received his first PhD in Telecommunication Engineering (Cum Laude) from the University of Navarra, Spain, in 2006, and a second PhD in Computational Intelligence (Summa Cum Laude) from the University of Alcala, Spain, in 2013. He is currently a principal researcher in data analytics and optimisation at TECNALIA (Spain), a visiting fellow at the Basque Center for Applied Mathematics (BCAM) and a part-time lecturer at the University of the Basque Country (UPV/EHU). His research interests gravitate on the use of descriptive, prescriptive and predictive algorithms for data mining and optimization in a diverse range of application fields such as Energy, Transport, Telecommunications, Health and Industry, among others. In these fields he has published more than 240 articles, co-supervised 8 Ph.D. theses, edited 6 books, coauthored 7 patents and participated/led more than 40 research projects. He is a Senior Member of the IEEE, and a recipient of the Biscay Talent prize for his academic career.",institutionString:"Tecnalia Research & Innovation",institution:{name:"Tecnalia",institutionURL:null,country:{name:"Spain"}}}]},{type:"book",id:"7656",title:"Fuzzy Logic",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7656.jpg",slug:"fuzzy-logic",publishedDate:"February 5th 2020",editedByType:"Edited by",bookSignature:"Constantin Volosencu",hash:"54f092d4ffe0abf5e4172a80025019bc",volumeInSeries:3,fullTitle:"Fuzzy Logic",editors:[{id:"1063",title:"Prof.",name:"Constantin",middleName:null,surname:"Volosencu",slug:"constantin-volosencu",fullName:"Constantin Volosencu",profilePictureURL:"https://mts.intechopen.com/storage/users/1063/images/system/1063.png",biography:"Prof. Dr. Constantin Voloşencu graduated as an engineer from\nPolitehnica University of Timișoara, Romania, where he also\nobtained a doctorate degree. He is currently a full professor in\nthe Department of Automation and Applied Informatics at the\nsame university. Dr. Voloşencu is the author of ten books, seven\nbook chapters, and more than 160 papers published in journals\nand conference proceedings. He has also edited twelve books and\nhas twenty-seven patents to his name. He is a manager of research grants, editor in\nchief and member of international journal editorial boards, a former plenary speaker, a member of scientific committees, and chair at international conferences. His\nresearch is in the fields of control systems, control of electric drives, fuzzy control\nsystems, neural network applications, fault detection and diagnosis, sensor network\napplications, monitoring of distributed parameter systems, and power ultrasound\napplications. He has developed automation equipment for machine tools, spooling\nmachines, high-power ultrasound processes, and more.",institutionString:"Polytechnic University of Timişoara",institution:{name:"Polytechnic University of Timişoara",institutionURL:null,country:{name:"Romania"}}}]},{type:"book",id:"9963",title:"Advances and Applications in Deep Learning",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9963.jpg",slug:"advances-and-applications-in-deep-learning",publishedDate:"December 9th 2020",editedByType:"Edited by",bookSignature:"Marco Antonio Aceves-Fernandez",hash:"0d51ba46f22e55cb89140f60d86a071e",volumeInSeries:4,fullTitle:"Advances and Applications in Deep Learning",editors:[{id:"24555",title:"Dr.",name:"Marco Antonio",middleName:null,surname:"Aceves Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves Fernandez",profilePictureURL:"https://mts.intechopen.com/storage/users/24555/images/system/24555.jpg",biography:"Dr. Marco Antonio Aceves Fernandez obtained his B.Sc. (Eng.) in Telematics from the Universidad de Colima, Mexico. He obtained both his M.Sc. and Ph.D. from the University of Liverpool, England, in the field of Intelligent Systems. He is a full professor at the Universidad Autonoma de Queretaro, Mexico, and a member of the National System of Researchers (SNI) since 2009. Dr. Aceves Fernandez has published more than 80 research papers as well as a number of book chapters and congress papers. He has contributed in more than 20 funded research projects, both academic and industrial, in the area of artificial intelligence, ranging from environmental, biomedical, automotive, aviation, consumer, and robotics to other applications. He is also a honorary president at the National Association of Embedded Systems (AMESE), a senior member of the IEEE, and a board member of many institutions. His research interests include intelligent and embedded systems.",institutionString:"Universidad Autonoma de Queretaro",institution:{name:"Autonomous University of Queretaro",institutionURL:null,country:{name:"Mexico"}}}]}]},openForSubmissionBooks:{paginationCount:3,paginationItems:[{id:"11446",title:"Industry 4.0 - Perspectives and Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11446.jpg",hash:"be984f45b90c1003798661ef885d8a34",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"May 12th 2022",isOpenForSubmission:!0,editors:[{id:"303193",title:"Dr.",name:"Meisam",surname:"Gordan",slug:"meisam-gordan",fullName:"Meisam Gordan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11448",title:"Artificial Neural Networks - Recent Advances, New Perspectives and Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11448.jpg",hash:"e57ff97a39cfc6fe68a1ac62b503dbe9",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"June 3rd 2022",isOpenForSubmission:!0,editors:[{id:"22866",title:"Dr.",name:"Chi Leung Patrick",surname:"Hui",slug:"chi-leung-patrick-hui",fullName:"Chi Leung Patrick Hui"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11447",title:"Swarm Intelligence - Recent Advances and Current Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11447.jpg",hash:"f68e3c3430a74fc7a7eb97f6ea2bb42e",secondStepPassed:!1,currentStepOfPublishingProcess:2,submissionDeadline:"July 22nd 2022",isOpenForSubmission:!0,editors:[{id:"24555",title:"Dr.",name:"Marco Antonio",surname:"Aceves Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves Fernandez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:3,paginationItems:[{id:"82362",title:"Studies on the Short-Term Effects of the Cease of Pesticides Use on Vineyard Microbiome",doi:"10.5772/intechopen.105706",signatures:"Simona Ghiță, Mihaela Hnatiuc, Aurora Ranca, Victoria Artem and Mădălina-Andreea Ciocan",slug:"studies-on-the-short-term-effects-of-the-cease-of-pesticides-use-on-vineyard-microbiome",totalDownloads:13,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Vegetation Dynamics, Changing Ecosystems and Human Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11663.jpg",subseries:{id:"40",title:"Ecosystems and Biodiversity"}}},{id:"82297",title:"The Climate Change-Agriculture Nexus in Drylands of Ethiopia",doi:"10.5772/intechopen.103905",signatures:"Zenebe Mekonnen",slug:"the-climate-change-agriculture-nexus-in-drylands-of-ethiopia",totalDownloads:22,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Vegetation Dynamics, Changing Ecosystems and Human Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11663.jpg",subseries:{id:"40",title:"Ecosystems and Biodiversity"}}},{id:"81999",title:"Climate Change, Rural Livelihoods, and Human Well-Being: Experiences from Kenya",doi:"10.5772/intechopen.104965",signatures:"André J. Pelser and Rujeko Samanthia Chimukuche",slug:"climate-change-rural-livelihoods-and-human-well-being-experiences-from-kenya",totalDownloads:26,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Vegetation Dynamics, Changing Ecosystems and Human Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11663.jpg",subseries:{id:"40",title:"Ecosystems and Biodiversity"}}}]},subseriesFiltersForOFChapters:[{caption:"Ecosystems and Biodiversity",value:40,count:3,group:"subseries"}],publishedBooks:{paginationCount:1,paginationItems:[{type:"book",id:"10843",title:"Persistent Organic Pollutants (POPs)",subtitle:"Monitoring, Impact and Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10843.jpg",slug:"persistent-organic-pollutants-pops-monitoring-impact-and-treatment",publishedDate:"April 13th 2022",editedByType:"Edited by",bookSignature:"Mohamed Nageeb Rashed",hash:"f5b1589f0a990b6114fef2dadc735dd9",volumeInSeries:1,fullTitle:"Persistent Organic Pollutants (POPs) - Monitoring, Impact and Treatment",editors:[{id:"63465",title:"Prof.",name:"Mohamed Nageeb",middleName:null,surname:"Rashed",slug:"mohamed-nageeb-rashed",fullName:"Mohamed Nageeb Rashed",profilePictureURL:"https://mts.intechopen.com/storage/users/63465/images/system/63465.gif",institutionString:null,institution:{name:"Aswan University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Pollution",value:38,count:1}],publicationYearFilters:[{group:"publicationYear",caption:"2022",value:2022,count:1}],authors:{paginationCount:303,paginationItems:[{id:"313921",title:"Dr.",name:"Hassan M.",middleName:null,surname:"Heshmati",slug:"hassan-m.-heshmati",fullName:"Hassan M. Heshmati",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/313921/images/system/313921.jpg",biography:"Dr. Hassan Massoud Heshmati is an endocrinologist with 46 years of experience in clinical research in academia (university-affiliated hospitals, Paris, France; Mayo Foundation, Rochester, MN, USA) and pharmaceutical companies (Sanofi, Malvern, PA, USA; Essentialis, Carlsbad, CA, USA; Gelesis, Boston, MA, USA). His research activity focuses on pituitary tumors, hyperthyroidism, thyroid cancers, osteoporosis, diabetes, and obesity. He has extensive knowledge in the development of anti-obesity products. Dr. Heshmati is the author of 299 abstracts, chapters, and articles related to endocrinology and metabolism. He is currently a consultant at Endocrinology Metabolism Consulting, LLC, Anthem, AZ, USA.",institutionString:"Endocrinology Metabolism Consulting, LLC",institution:null},{id:"76477",title:"Prof.",name:"Mirza",middleName:null,surname:"Hasanuzzaman",slug:"mirza-hasanuzzaman",fullName:"Mirza Hasanuzzaman",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/76477/images/system/76477.png",biography:"Dr. Mirza Hasanuzzaman is a Professor of Agronomy at Sher-e-Bangla Agricultural University, Bangladesh. He received his Ph.D. in Plant Stress Physiology and Antioxidant Metabolism from Ehime University, Japan, with a scholarship from the Japanese Government (MEXT). Later, he completed his postdoctoral research at the Center of Molecular Biosciences, University of the Ryukyus, Japan, as a recipient of the Japan Society for the Promotion of Science (JSPS) postdoctoral fellowship. He was also the recipient of the Australian Government Endeavour Research Fellowship for postdoctoral research as an adjunct senior researcher at the University of Tasmania, Australia. Dr. Hasanuzzaman’s current work is focused on the physiological and molecular mechanisms of environmental stress tolerance. Dr. Hasanuzzaman has published more than 150 articles in peer-reviewed journals. He has edited ten books and written more than forty book chapters on important aspects of plant physiology, plant stress tolerance, and crop production. According to Scopus, Dr. Hasanuzzaman’s publications have received more than 10,500 citations with an h-index of 53. He has been named a Highly Cited Researcher by Clarivate. He is an editor and reviewer for more than fifty peer-reviewed international journals and was a recipient of the “Publons Peer Review Award” in 2017, 2018, and 2019. He has been honored by different authorities for his outstanding performance in various fields like research and education, and he has received the World Academy of Science Young Scientist Award (2014) and the University Grants Commission (UGC) Award 2018. He is a fellow of the Bangladesh Academy of Sciences (BAS) and the Royal Society of Biology.",institutionString:"Sher-e-Bangla Agricultural University",institution:{name:"Sher-e-Bangla Agricultural University",country:{name:"Bangladesh"}}},{id:"187859",title:"Prof.",name:"Kusal",middleName:"K.",surname:"Das",slug:"kusal-das",fullName:"Kusal Das",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSBDeQAO/Profile_Picture_1623411145568",biography:"Kusal K. Das is a Distinguished Chair Professor of Physiology, Shri B. M. Patil Medical College and Director, Centre for Advanced Medical Research (CAMR), BLDE (Deemed to be University), Vijayapur, Karnataka, India. Dr. Das did his M.S. and Ph.D. in Human Physiology from the University of Calcutta, Kolkata. His area of research is focused on understanding of molecular mechanisms of heavy metal activated low oxygen sensing pathways in vascular pathophysiology. He has invented a new method of estimation of serum vitamin E. His expertise in critical experimental protocols on vascular functions in experimental animals was well documented by his quality of publications. He was a Visiting Professor of Medicine at University of Leeds, United Kingdom (2014-2016) and Tulane University, New Orleans, USA (2017). For his immense contribution in medical research Ministry of Science and Technology, Government of India conferred him 'G.P. Chatterjee Memorial Research Prize-2019” and he is also the recipient of 'Dr.Raja Ramanna State Scientist Award 2015” by Government of Karnataka. He is a Fellow of the Royal Society of Biology (FRSB), London and Honorary Fellow of Karnataka Science and Technology Academy, Department of Science and Technology, Government of Karnataka.",institutionString:"BLDE (Deemed to be University), India",institution:null},{id:"243660",title:"Dr.",name:"Mallanagouda Shivanagouda",middleName:null,surname:"Biradar",slug:"mallanagouda-shivanagouda-biradar",fullName:"Mallanagouda Shivanagouda Biradar",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/243660/images/system/243660.jpeg",biography:"M. S. Biradar is Vice Chancellor and Professor of Medicine of\nBLDE (Deemed to be University), Vijayapura, Karnataka, India.\nHe obtained his MD with a gold medal in General Medicine and\nhas devoted himself to medical teaching, research, and administrations. He has also immensely contributed to medical research\non vascular medicine, which is reflected by his numerous publications including books and book chapters. Professor Biradar was\nalso Visiting Professor at Tulane University School of Medicine, New Orleans, USA.",institutionString:"BLDE (Deemed to be University)",institution:{name:"BLDE University",country:{name:"India"}}},{id:"289796",title:"Dr.",name:"Swastika",middleName:null,surname:"Das",slug:"swastika-das",fullName:"Swastika Das",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/289796/images/system/289796.jpeg",biography:"Swastika N. Das is Professor of Chemistry at the V. P. Dr. P. G.\nHalakatti College of Engineering and Technology, BLDE (Deemed\nto be University), Vijayapura, Karnataka, India. She obtained an\nMSc, MPhil, and PhD in Chemistry from Sambalpur University,\nOdisha, India. Her areas of research interest are medicinal chemistry, chemical kinetics, and free radical chemistry. She is a member\nof the investigators who invented a new modified method of estimation of serum vitamin E. She has authored numerous publications including book\nchapters and is a mentor of doctoral curriculum at her university.",institutionString:"BLDEA’s V.P.Dr.P.G.Halakatti College of Engineering & Technology",institution:{name:"BLDE University",country:{name:"India"}}},{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/248459/images/system/248459.png",biography:"Akikazu Takada was born in Japan, 1935. After graduation from\nKeio University School of Medicine and finishing his post-graduate studies, he worked at Roswell Park Memorial Institute NY,\nUSA. He then took a professorship at Hamamatsu University\nSchool of Medicine. In thrombosis studies, he found the SK\npotentiator that enhances plasminogen activation by streptokinase. He is very much interested in simultaneous measurements\nof fatty acids, amino acids, and tryptophan degradation products. By using fatty\nacid analyses, he indicated that plasma levels of trans-fatty acids of old men were\nfar higher in the US than Japanese men. . He also showed that eicosapentaenoic acid\n(EPA) and docosahexaenoic acid (DHA) levels are higher, and arachidonic acid\nlevels are lower in Japanese than US people. By using simultaneous LC/MS analyses\nof plasma levels of tryptophan metabolites, he recently found that plasma levels of\nserotonin, kynurenine, or 5-HIAA were higher in patients of mono- and bipolar\ndepression, which are significantly different from observations reported before. In\nview of recent reports that plasma tryptophan metabolites are mainly produced by\nmicrobiota. He is now working on the relationships between microbiota and depression or autism.",institutionString:"Hamamatsu University School of Medicine",institution:{name:"Hamamatsu University School of Medicine",country:{name:"Japan"}}},{id:"137240",title:"Prof.",name:"Mohammed",middleName:null,surname:"Khalid",slug:"mohammed-khalid",fullName:"Mohammed Khalid",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/137240/images/system/137240.png",biography:"Mohammed Khalid received his B.S. in Chemistry in July 2000, and his Ph.D. in Physical Chemistry in 2007 from the University of Khartoum, Sudan. In 2009 he joined the Dr. Ron Clarke research group at the School of Chemistry, Faculty of Science, University of Sydney, Australia as a postdoctoral fellow where he worked on the Interaction of ATP with the phosphoenzyme of the Na+, K+-ATPase, and Dual mechanisms of allosteric acceleration of the Na+, K+-ATPase by ATP. He then worked as Assistant Professor at the Department of Chemistry, University of Khartoum, and in 2014 was promoted to Associate Professor ranking. In 2011 he joined the staff of the Chemistry Department at Taif University, Saudi Arabia, where he is currently active as an Assistant Professor. His research interests include:\r\n(1) P-type ATPase Enzyme Kinetics and Mechanisms; (2) Kinetics and Mechanism of Redox Reactions; (3) Autocatalytic reactions; (4) Computational enzyme kinetics; (5) Allosteric acceleration of P-type ATPases by ATP; (6) Exploring of allosteric sites of ATPases and interaction of ATP with ATPases located in the cell membranes.",institutionString:"Taif University",institution:{name:"Taif University",country:{name:"Saudi Arabia"}}},{id:"63810",title:"Prof.",name:"Jorge",middleName:null,surname:"Morales-Montor",slug:"jorge-morales-montor",fullName:"Jorge Morales-Montor",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/63810/images/system/63810.png",biography:"Dr. Jorge Morales-Montor was recognized with the Lola and Igo Flisser PUIS Award for best graduate thesis at the national level in the field of parasitology. He received a fellowship from the Fogarty Foundation to perform postdoctoral research stay at the University of Georgia. He has 153 journal articles to his credit. He has also edited several books and published more than fifty-five book chapters. He is a member of the Mexican Academy of Sciences, Latin American Academy of Sciences, and the National Academy of Medicine. He has received more than thirty-five awards and has supervised numerous bachelor’s, master’s, and Ph.D. students. Dr. Morales-Montor is the past president of the Mexican Society of Parasitology.",institutionString:"National Autonomous University of Mexico",institution:{name:"National Autonomous University of Mexico",country:{name:"Mexico"}}},{id:"217215",title:"Dr.",name:"Palash",middleName:null,surname:"Mandal",slug:"palash-mandal",fullName:"Palash Mandal",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/217215/images/system/217215.jpeg",biography:null,institutionString:"Charusat University",institution:null},{id:"49739",title:"Dr.",name:"Leszek",middleName:null,surname:"Szablewski",slug:"leszek-szablewski",fullName:"Leszek Szablewski",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/49739/images/system/49739.jpg",biography:"Leszek Szablewski is a professor of medical sciences. He received his M.S. in the Faculty of Biology from the University of Warsaw and his PhD degree from the Institute of Experimental Biology Polish Academy of Sciences. He habilitated in the Medical University of Warsaw, and he obtained his degree of Professor from the President of Poland. Professor Szablewski is the Head of Chair and Department of General Biology and Parasitology, Medical University of Warsaw. Professor Szablewski has published over 80 peer-reviewed papers in journals such as Journal of Alzheimer’s Disease, Biochim. Biophys. Acta Reviews of Cancer, Biol. Chem., J. Biomed. Sci., and Diabetes/Metabol. Res. Rev, Endocrine. He is the author of two books and four book chapters. He has edited four books, written 15 scripts for students, is the ad hoc reviewer of over 30 peer-reviewed journals, and editorial member of peer-reviewed journals. Prof. Szablewski’s research focuses on cell physiology, genetics, and pathophysiology. He works on the damage caused by lack of glucose homeostasis and changes in the expression and/or function of glucose transporters due to various diseases. He has given lectures, seminars, and exercises for students at the Medical University.",institutionString:"Medical University of Warsaw",institution:{name:"Medical University of Warsaw",country:{name:"Poland"}}},{id:"173123",title:"Dr.",name:"Maitham",middleName:null,surname:"Khajah",slug:"maitham-khajah",fullName:"Maitham Khajah",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/173123/images/system/173123.jpeg",biography:"Dr. Maitham A. Khajah received his degree in Pharmacy from Faculty of Pharmacy, Kuwait University, in 2003 and obtained his PhD degree in December 2009 from the University of Calgary, Canada (Gastrointestinal Science and Immunology). Since January 2010 he has been assistant professor in Kuwait University, Faculty of Pharmacy, Department of Pharmacology and Therapeutics. His research interest are molecular targets for the treatment of inflammatory bowel disease (IBD) and the mechanisms responsible for immune cell chemotaxis. He cosupervised many students for the MSc Molecular Biology Program, College of Graduate Studies, Kuwait University. Ever since joining Kuwait University in 2010, he got various grants as PI and Co-I. He was awarded the Best Young Researcher Award by Kuwait University, Research Sector, for the Year 2013–2014. He was a member in the organizing committee for three conferences organized by Kuwait University, Faculty of Pharmacy, as cochair and a member in the scientific committee (the 3rd, 4th, and 5th Kuwait International Pharmacy Conference).",institutionString:"Kuwait University",institution:{name:"Kuwait University",country:{name:"Kuwait"}}},{id:"195136",title:"Dr.",name:"Aya",middleName:null,surname:"Adel",slug:"aya-adel",fullName:"Aya Adel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/195136/images/system/195136.jpg",biography:"Dr. Adel works as an Assistant Lecturer in the unit of Phoniatrics, Department of Otolaryngology, Ain Shams University in Cairo, Egypt. Dr. Adel is especially interested in joint attention and its impairment in autism spectrum disorder",institutionString:"Ain Shams University",institution:{name:"Ain Shams University",country:{name:"Egypt"}}},{id:"94911",title:"Dr.",name:"Boulenouar",middleName:null,surname:"Mesraoua",slug:"boulenouar-mesraoua",fullName:"Boulenouar Mesraoua",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/94911/images/system/94911.png",biography:"Dr Boulenouar Mesraoua is the Associate Professor of Clinical Neurology at Weill Cornell Medical College-Qatar and a Consultant Neurologist at Hamad Medical Corporation at the Neuroscience Department; He graduated as a Medical Doctor from the University of Oran, Algeria; he then moved to Belgium, the City of Liege, for a Residency in Internal Medicine and Neurology at Liege University; after getting the Belgian Board of Neurology (with high marks), he went to the National Hospital for Nervous Diseases, Queen Square, London, United Kingdom for a fellowship in Clinical Neurophysiology, under Pr Willison ; Dr Mesraoua had also further training in Epilepsy and Continuous EEG Monitoring for two years (from 2001-2003) in the Neurophysiology department of Zurich University, Switzerland, under late Pr Hans Gregor Wieser ,an internationally known epileptologist expert. \n\nDr B. Mesraoua is the Director of the Neurology Fellowship Program at the Neurology Section and an active member of the newly created Comprehensive Epilepsy Program at Hamad General Hospital, Doha, Qatar; he is also Assistant Director of the Residency Program at the Qatar Medical School. \nDr B. Mesraoua's main interests are Epilepsy, Multiple Sclerosis, and Clinical Neurology; He is the Chairman and the Organizer of the well known Qatar Epilepsy Symposium, he is running yearly for the past 14 years and which is considered a landmark in the Gulf region; He has also started last year , together with other epileptologists from Qatar, the region and elsewhere, a yearly International Epilepsy School Course, which was attended by many neurologists from the Area.\n\nInternationally, Dr Mesraoua is an active and elected member of the Commission on Eastern Mediterranean Region (EMR ) , a regional branch of the International League Against Epilepsy (ILAE), where he represents the Middle East and North Africa(MENA ) and where he holds the position of chief of the Epilepsy Epidemiology Section; Dr Mesraoua is a member of the American Academy of Neurology, the Europeen Academy of Neurology and the American Epilepsy Society.\n\nDr Mesraoua's main objectives are to encourage frequent gathering of the epileptologists/neurologists from the MENA region and the rest of the world, promote Epilepsy Teaching in the MENA Region, and encourage multicenter studies involving neurologists and epileptologists in the MENA region, particularly epilepsy epidemiological studies. \n\nDr. Mesraoua is the recipient of two research Grants, as the Lead Principal Investigator (750.000 USD and 250.000 USD) from the Qatar National Research Fund (QNRF) and the Hamad Hospital Internal Research Grant (IRGC), on the following topics : “Continuous EEG Monitoring in the ICU “ and on “Alpha-lactoalbumin , proof of concept in the treatment of epilepsy” .Dr Mesraoua is a reviewer for the journal \"seizures\" (Europeen Epilepsy Journal ) as well as dove journals ; Dr Mesraoua is the author and co-author of many peer reviewed publications and four book chapters in the field of Epilepsy and Clinical Neurology",institutionString:"Weill Cornell Medical College in Qatar",institution:{name:"Weill Cornell Medical College in Qatar",country:{name:"Qatar"}}},{id:"282429",title:"Prof.",name:"Covanis",middleName:null,surname:"Athanasios",slug:"covanis-athanasios",fullName:"Covanis Athanasios",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/282429/images/system/282429.jpg",biography:null,institutionString:"Neurology-Neurophysiology Department of the Children Hospital Agia Sophia",institution:null},{id:"190980",title:"Prof.",name:"Marwa",middleName:null,surname:"Mahmoud Saleh",slug:"marwa-mahmoud-saleh",fullName:"Marwa Mahmoud Saleh",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/190980/images/system/190980.jpg",biography:"Professor Marwa Mahmoud Saleh is a doctor of medicine and currently works in the unit of Phoniatrics, Department of Otolaryngology, Ain Shams University in Cairo, Egypt. She got her doctoral degree in 1991 and her doctoral thesis was accomplished in the University of Iowa, United States. Her publications covered a multitude of topics as videokymography, cochlear implants, stuttering, and dysphagia. She has lectured Egyptian phonology for many years. Her recent research interest is joint attention in autism.",institutionString:"Ain Shams University",institution:{name:"Ain Shams University",country:{name:"Egypt"}}},{id:"259190",title:"Dr.",name:"Syed Ali Raza",middleName:null,surname:"Naqvi",slug:"syed-ali-raza-naqvi",fullName:"Syed Ali Raza Naqvi",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259190/images/system/259190.png",biography:"Dr. Naqvi is a radioanalytical chemist and is working as an associate professor of analytical chemistry in the Department of Chemistry, Government College University, Faisalabad, Pakistan. Advance separation techniques, nuclear analytical techniques and radiopharmaceutical analysis are the main courses that he is teaching to graduate and post-graduate students. In the research area, he is focusing on the development of organic- and biomolecule-based radiopharmaceuticals for diagnosis and therapy of infectious and cancerous diseases. Under the supervision of Dr. Naqvi, three students have completed their Ph.D. degrees and 41 students have completed their MS degrees. He has completed three research projects and is currently working on 2 projects entitled “Radiolabeling of fluoroquinolone derivatives for the diagnosis of deep-seated bacterial infections” and “Radiolabeled minigastrin peptides for diagnosis and therapy of NETs”. He has published about 100 research articles in international reputed journals and 7 book chapters. Pakistan Institute of Nuclear Science & Technology (PINSTECH) Islamabad, Punjab Institute of Nuclear Medicine (PINM), Faisalabad and Institute of Nuclear Medicine and Radiology (INOR) Abbottabad are the main collaborating institutes.",institutionString:"Government College University",institution:{name:"Government College University, Faisalabad",country:{name:"Pakistan"}}},{id:"58390",title:"Dr.",name:"Gyula",middleName:null,surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/58390/images/system/58390.png",biography:"Gyula Mózsik MD, Ph.D., ScD (med), is an emeritus professor of Medicine at the First Department of Medicine, Univesity of Pécs, Hungary. He was head of this department from 1993 to 2003. His specializations are medicine, gastroenterology, clinical pharmacology, clinical nutrition, and dietetics. His research fields are biochemical pharmacological examinations in the human gastrointestinal (GI) mucosa, mechanisms of retinoids, drugs, capsaicin-sensitive afferent nerves, and innovative pharmacological, pharmaceutical, and nutritional (dietary) research in humans. He has published about 360 peer-reviewed papers, 197 book chapters, 692 abstracts, 19 monographs, and has edited 37 books. He has given about 1120 regular and review lectures. He has organized thirty-eight national and international congresses and symposia. He is the founder of the International Conference on Ulcer Research (ICUR); International Union of Pharmacology, Gastrointestinal Section (IUPHAR-GI); Brain-Gut Society symposiums, and gastrointestinal cytoprotective symposiums. He received the Andre Robert Award from IUPHAR-GI in 2014. Fifteen of his students have been appointed as full professors in Egypt, Cuba, and Hungary.",institutionString:"University of Pécs",institution:{name:"University of Pecs",country:{name:"Hungary"}}},{id:"277367",title:"M.Sc.",name:"Daniel",middleName:"Martin",surname:"Márquez López",slug:"daniel-marquez-lopez",fullName:"Daniel Márquez López",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/277367/images/7909_n.jpg",biography:"Msc Daniel Martin Márquez López has a bachelor degree in Industrial Chemical Engineering, a Master of science degree in the same área and he is a PhD candidate for the Instituto Politécnico Nacional. His Works are realted to the Green chemistry field, biolubricants, biodiesel, transesterification reactions for biodiesel production and the manipulation of oils for therapeutic purposes.",institutionString:null,institution:{name:"Instituto Politécnico Nacional",country:{name:"Mexico"}}},{id:"196544",title:"Prof.",name:"Angel",middleName:null,surname:"Catala",slug:"angel-catala",fullName:"Angel Catala",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/196544/images/system/196544.jpg",biography:"Angel Catalá studied chemistry at Universidad Nacional de La Plata, Argentina, where he received a Ph.D. in Chemistry (Biological Branch) in 1965. From 1964 to 1974, he worked as an Assistant in Biochemistry at the School of Medicine at the same university. From 1974 to 1976, he was a fellow of the National Institutes of Health (NIH) at the University of Connecticut, Health Center, USA. From 1985 to 2004, he served as a Full Professor of Biochemistry at the Universidad Nacional de La Plata. He is a member of the National Research Council (CONICET), Argentina, and the Argentine Society for Biochemistry and Molecular Biology (SAIB). His laboratory has been interested for many years in the lipid peroxidation of biological membranes from various tissues and different species. Dr. Catalá has directed twelve doctoral theses, published more than 100 papers in peer-reviewed journals, several chapters in books, and edited twelve books. He received awards at the 40th International Conference Biochemistry of Lipids 1999 in Dijon, France. He is the winner of the Bimbo Pan-American Nutrition, Food Science and Technology Award 2006 and 2012, South America, Human Nutrition, Professional Category. In 2006, he won the Bernardo Houssay award in pharmacology, in recognition of his meritorious works of research. Dr. Catalá belongs to the editorial board of several journals including Journal of Lipids; International Review of Biophysical Chemistry; Frontiers in Membrane Physiology and Biophysics; World Journal of Experimental Medicine and Biochemistry Research International; World Journal of Biological Chemistry, Diabetes, and the Pancreas; International Journal of Chronic Diseases & Therapy; and International Journal of Nutrition. He is the co-editor of The Open Biology Journal and associate editor for Oxidative Medicine and Cellular Longevity.",institutionString:"Universidad Nacional de La Plata",institution:{name:"National University of La Plata",country:{name:"Argentina"}}},{id:"186585",title:"Dr.",name:"Francisco Javier",middleName:null,surname:"Martin-Romero",slug:"francisco-javier-martin-romero",fullName:"Francisco Javier Martin-Romero",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSB3HQAW/Profile_Picture_1631258137641",biography:"Francisco Javier Martín-Romero (Javier) is a Professor of Biochemistry and Molecular Biology at the University of Extremadura, Spain. He is also a group leader at the Biomarkers Institute of Molecular Pathology. Javier received his Ph.D. in 1998 in Biochemistry and Biophysics. At the National Cancer Institute (National Institute of Health, Bethesda, MD) he worked as a research associate on the molecular biology of selenium and its role in health and disease. After postdoctoral collaborations with Carlos Gutierrez-Merino (University of Extremadura, Spain) and Dario Alessi (University of Dundee, UK), he established his own laboratory in 2008. The interest of Javier's lab is the study of cell signaling with a special focus on Ca2+ signaling, and how Ca2+ transport modulates the cytoskeleton, migration, differentiation, cell death, etc. He is especially interested in the study of Ca2+ channels, and the role of STIM1 in the initiation of pathological events.",institutionString:null,institution:{name:"University of Extremadura",country:{name:"Spain"}}},{id:"198499",title:"Dr.",name:"Daniel",middleName:null,surname:"Glossman-Mitnik",slug:"daniel-glossman-mitnik",fullName:"Daniel Glossman-Mitnik",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/198499/images/system/198499.jpeg",biography:"Dr. Daniel Glossman-Mitnik is currently a Titular Researcher at the Centro de Investigación en Materiales Avanzados (CIMAV), Chihuahua, Mexico, as well as a National Researcher of Level III at the Consejo Nacional de Ciencia y Tecnología, México. His research interest focuses on computational chemistry and molecular modeling of diverse systems of pharmacological, food, and alternative energy interests by resorting to DFT and Conceptual DFT. He has authored a coauthored more than 270 peer-reviewed papers, 32 book chapters, and 4 edited books. He has delivered speeches at many international and domestic conferences. He serves as a reviewer for more than eighty international journals, books, and research proposals as well as an editor for special issues of renowned scientific journals.",institutionString:null,institution:null},{id:"217323",title:"Prof.",name:"Guang-Jer",middleName:null,surname:"Wu",slug:"guang-jer-wu",fullName:"Guang-Jer Wu",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/217323/images/8027_n.jpg",biography:null,institutionString:null,institution:null},{id:"148546",title:"Dr.",name:"Norma Francenia",middleName:null,surname:"Santos-Sánchez",slug:"norma-francenia-santos-sanchez",fullName:"Norma Francenia Santos-Sánchez",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/148546/images/4640_n.jpg",biography:null,institutionString:null,institution:null},{id:"272889",title:"Dr.",name:"Narendra",middleName:null,surname:"Maddu",slug:"narendra-maddu",fullName:"Narendra Maddu",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/272889/images/10758_n.jpg",biography:null,institutionString:null,institution:null},{id:"242491",title:"Prof.",name:"Angelica",middleName:null,surname:"Rueda",slug:"angelica-rueda",fullName:"Angelica Rueda",position:"Investigador Cinvestav 3B",profilePictureURL:"https://mts.intechopen.com/storage/users/242491/images/6765_n.jpg",biography:null,institutionString:null,institution:null},{id:"88631",title:"Dr.",name:"Ivan",middleName:null,surname:"Petyaev",slug:"ivan-petyaev",fullName:"Ivan Petyaev",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Lycotec (United Kingdom)",country:{name:"United Kingdom"}}},{id:"428313",title:"Dr.",name:"Sambangi",middleName:null,surname:"Pratyusha",slug:"sambangi-pratyusha",fullName:"Sambangi Pratyusha",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"CGIAR",country:{name:"France"}}},{id:"423869",title:"Ms.",name:"Smita",middleName:null,surname:"Rai",slug:"smita-rai",fullName:"Smita Rai",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Integral University",country:{name:"India"}}},{id:"424024",title:"Prof.",name:"Swati",middleName:null,surname:"Sharma",slug:"swati-sharma",fullName:"Swati Sharma",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Integral University",country:{name:"India"}}},{id:"439112",title:"MSc.",name:"Touseef",middleName:null,surname:"Fatima",slug:"touseef-fatima",fullName:"Touseef Fatima",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Integral University",country:{name:"India"}}}]}},subseries:{item:{id:"93",type:"subseries",title:"Inclusivity and Social Equity",keywords:"Social contract, SDG, Human rights, Inclusiveness, Equity, Democracy, Personal learning, Collaboration, Glocalization",scope:"